[
  {
    "contract_id": "2ThemartComInc_19990826_10-12G_EX-10.10_6700288_EX-10.10_Co-Branding Agreement_ Agency Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding and Advertising Agreement between i-Escrow, Inc. and 2TheMart.com, Inc.:\n\n**Purpose:** The agreement aims to establish a co-branded website (Co-Branded Site) where 2TheMart.com, Inc. will promote i-Escrow's escrow services to its auction users, and i-Escrow will develop the Co-Branded Site and implement the Information Transfer Mechanism to make services available seamlessly to customers.\n\n**Obligations:**\n\n* 2TheMart.com, Inc. will promote i-Escrow's services to its auction users.\n* i-Escrow, Inc. will develop the Co-Branded Site and implement the Information Transfer Mechanism.\n* Both parties will be responsible for their respective development, hosting, and other costs associated with the Co-Branded Site.\n\n**Risks:** Failure to agree on the initial operation of the Information Transfer Mechanism within 2 months may result in termination of the agreement. Additionally, the parties may face risks associated with the development and implementation of the Co-Branded Site, including delays, costs overruns, and technical issues.",
    "termination": "8.4 TERMINATION FOR BANKRUPTCY. Either party may terminate\nor suspend this Agreement upon the occurrence of any of the\nfollowing events: (a) the other party files a petition for\nbankruptcy or becomes insolvent; (b) the other party makes\nan assignment for the benefit of creditors; or (c) a\nreceiver is appointed for the other party or its assets.",
    "confidentiality": "Each party shall hold the other party's Confidential Information in confidence and shall not disclose such Confidential Information to third parties nor use the other party's Confidential Information for any purpose other than as required to perform under this Agreement.",
    "liability": "Either party may terminate or suspend this Agreement effective immediately and without liability upon written notice to the other party if any one of the following events occurs:"
  },
  {
    "contract_id": "AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement",
    "summary": "Here is a 100-150 word summary of the License, Development and Commercialization Agreement between Xencor, Inc. and Aimmune Therapeutics, Inc., including purpose, obligations, and risks:\n\n**Purpose:** The agreement aims to license Xencor's intellectual property rights related to an antibody to Aimmune for further development and commercialization.\n\n**Obligations:**\n\n* Xencor grants Aimmune a license to develop, manufacture, and commercialize the antibody.\n* Aimmune is responsible for development, regulatory, and commercialization activities.\n* Both parties must maintain confidentiality and intellectual property rights.\n\n**Risks:** The agreement involves significant risks, including:\n* Competitive harm to Xencor if the agreement is publicly disclosed.\n* Uncertainty in the development and commercialization process.\n* Potential indemnification obligations for intellectual property infringement or other claims.\n* Termination or expiration of the agreement, which may impact future collaborations or revenue streams.",
    "termination": "\"\"ARTICLE 14 Effects of Expiration Or Termination 40\nARTICLE 15 Miscellaneous 43\"\"",
    "confidentiality": "\"\"\"ARTICLE 12 Confidentiality 39\n\n12.1 Confidential Information.  Each Party agrees that all Confidential Information disclosed to it by the other Party is confidential and\nproprietary to the disclosing Party.  The receiving Party agrees to use the Confidential Information solely for the purposes of exercising its\nrights and performing its obligations under this Agreement and not to disclose the Confidential Information to any third party without the\nprior written consent of the disclosing Party.  The receiving Party agrees to protect the Confidential Information with the same degree of care\nthat it protects its own confidential information, but in no event with less than reasonable care.  The obligations of confidentiality and\nnon-disclosure set forth in this Section 12.1 shall survive the expiration or termination of this Agreement for a period of five (5) years from\nthe date of expiration or termination of this Agreement.  The receiving Party's obligations under this Section 12.1 shall not apply to any\ninformation that is publicly available or becomes publicly available through no fault of the receiving Party, or is independently developed by\nthe receiving Party without use of or reference to the Confidential Information, or is received by the receiving Party from a third party who\nhas the right to disclose such information.  The receiving Party's obligations under this Section 12.1 shall not apply to any information that\nis required to be disclosed by law or by any governmental or regulatory authority, provided that the receiving Party gives the disclosing Party\nreasonable prior notice of such disclosure and cooperates with the disclosing Party in seeking a protective order or other remedy to\nmitigate the disclosure.  The receiving Party's obligations under this Section 12.1 shall not apply to any information that is disclosed to the\nreceiving Party's employees, agents, or contractors who need to know such information in order for the receiving Party to exercise its rights\nand perform its obligations under this Agreement, provided that such employees, agents, or contractors are bound by confidentiality\nobligations at least as protective of the Confidential Information as those set forth in this Section 12.1.  The receiving Party shall be liable\nfor any breach of this Section 12.1 by its employees, agents, or contractors.\n\n12.2 Return of Confidential Information.  Upon the expiration or termination of this Agreement, the receiving Party shall promptly return to\nthe disclosing Party all Confidential Information in its possession or control, including all copies and reproductions thereof.  The\nreceiving Party shall also destroy all Confidential Information in its possession or control, including all copies and reproductions thereof,\nand certify in writing to the disclosing Party that it has done so.  The receiving Party's obligations under this Section 12.2 shall survive the\nexpiration or termination of this Agreement for a period of five (5) years from the date of expiration or termination of this Agreement.\n\n12.3 Ownership of Confidential Information.  The disclosing Party retains all right, title, and interest in and to the Confidential Information\ndisclosed to the receiving Party, including all intellectual property rights related thereto.  The receiving Party acknowledges that it has no\nright, title, or interest in or to the Confidential Information disclosed to it by the disclosing Party, except as expressly granted to the\nreceiving Party under this Agreement.\n\n12.4 Remedies.  The disclosing Party shall be entitled to seek injunctive relief in the event of a breach or threatened breach of this Section\n12.1.  The disclosing Party shall also be entitled to seek damages for any breach or threatened breach of this Section 12.1, including\nreasonable attorneys' fees and costs.  The receiving Party acknowledges that a breach or threatened breach of this Section 12.1 may cause\nirreparable harm to the disclosing Party and that monetary damages may not be sufficient to compensate the disclosing Party for such\nharm.  The receiving Party agrees to waive any defense based on the adequacy of monetary damages in",
    "liability": "\"\"liability company, limited liability partnership, syndicate, person (including a\n“person” as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, together with the rules and regulations promulgated\nthereunder), trust, association, entity or government or political subdivision, agency or instrumentality of a government.\"\""
  },
  {
    "contract_id": "ArcaUsTreasuryFund_20200207_N-2_EX-99.K5_11971930_EX-99.K5_Development Agreement",
    "summary": "Here is a 100-150 word summary of the contract, including purpose, obligations, and risks:\n\n**Purpose:** The Blockchain Administration and Development Agreement is between ARCA U.S. Treasury Fund (the Fund) and ARCA Capital Management, LLC (the Blockchain Administrator). The purpose of the agreement is to retain the Blockchain Administrator to develop and administer ERC-1404 compatible digital securities for the Fund.\n\n**Obligations:** The Blockchain Administrator is responsible for providing development and administrative services necessary for the issuance and maintenance of the Fund's digital securities. This includes conducting relations with various parties, making reports to the Fund's Board, and providing advice and recommendations on certain aspects of the Fund's business. The Blockchain Administrator is also authorized to enter into agreements with other service providers to fulfill its responsibilities.\n\n**Risks:** The Fund bears all costs and expenses incurred in its operation, administration, and transactions, except for those specifically assumed by the Blockchain Administrator. The Blockchain Administrator is an independent contractor and has no authority to act for or represent the Fund. The Fund may be exposed to risks associated with the development and administration of digital securities, including technical and regulatory risks.",
    "termination": "\"\"The Blockchain Administrator further agrees that all records which it maintains for the Fund pursuant to Rule 31a-1 under the Investment Company Act will be preserved for the periods prescribed by Rule 31a-2 under the Investment Company Act unless any such records are earlier surrendered as provided above.\"\"",
    "confidentiality": "The parties hereto agree that each shall treat confidentially the terms and conditions of this Agreement and all information provided by each party to the other regarding its business and operations. All confidential information provided by a party hereto, including nonpublic personal information (regulated pursuant to Regulation S-P), shall be used by any other party hereto solely for the purpose of rendering services pursuant to this Agreement and, except as may be required in carrying out this Agreement, shall not be disclosed to any third party, without the prior consent of such providing party. The foregoing shall not be applicable to any information that is publicly available when provided or thereafter becomes publicly available other than through a breach of this Agreement, or that is required to be disclosed by any regulatory authority, any authority or legal counsel of the parties hereto, by judicial or administrative process or otherwise by applicable law or regulation.",
    "liability": "\"\"WHEREAS, the Fund bears all costs and expenses incurred in its operation, administration and transactions which are not specifically assumed by the Adviser pursuant to the Advisory Agreement or this Agreement.\"\""
  },
  {
    "contract_id": "ClickstreamCorp_20200330_1-A_EX1A-6 MAT CTRCT_12089935_EX1A-6 MAT CTRCT_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Application Development Agreement:\n\n**Purpose:** The purpose of this Agreement is for Clickstream Corporation (Client) to engage InfinixSoft Global LLC (Developer) as an independent contractor to design and develop a mobile software application (Application) on the terms and conditions outlined in the Agreement.\n\n**Obligations:**\n\n* The Client is obligated to pay the Developer according to the schedule set forth in Exhibit A, and to provide the necessary resources and support for the development of the Application.\n* The Developer is obligated to create the Application System as detailed in Exhibit A, perform the Services in a workmanlike manner, and provide satisfactory and acceptable results.\n\n**Risks:** The risks associated with this Agreement include the possibility of termination by either party, which may result in the Developer not receiving full compensation for their work. Additionally, the Client may cancel the agreement at any time within a 7-day notice period, while the Developer can only cancel due to lack of payment.",
    "termination": "\"(a) Types of Termination. This Agreement may be terminated:\n1. By either Party on provision of seven (7) days written notice to the other Party in case of a Force Majeure Event.\n2. Client has the unilateral right to cancel this agreement at any time within a 7-day notice period. Further, Developer can only cancel\ndue to lack of payment. Client will have a 30 day right to cure before a cancelation can occur.\n3. By either Party for a material breach of any provision of this Agreement by the other Party, if the other Party’s material breach is not\ncured within three (3) days of receipt of written notice thereof. This shall include any delays to the timeline specified in Exhibit A.\n4. By the Client at any time and without prior notice, if the Developer is convicted of any crime or offense, fails or refuses to comply\nwith the written policies or reasonable directives of the Client, or is guilty of serious misconduct in connection with performance\nunder this Agreement.\"",
    "confidentiality": "\"The Developer agrees, during the Term and thereafter, to hold in strictest confidence, and not to use, except for the benefit of the Client, or to disclose to any person, firm, or corporation without the prior written authorization of the Client, any Confidential Information of the Client.\"",
    "liability": "\"\"\"\"NOW THEREFORE, in consideration of the above recitals and the mutual promises and benefits contained herein, the Parties hereby agree as\nfollows:\"\"\"\n\n \n\n(No liability clause found in the provided text)"
  },
  {
    "contract_id": "CnsPharmaceuticalsInc_20200326_8-K_EX-10.1_12079626_EX-10.1_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Development Agreement between CNS Pharmaceuticals, Inc. and WPD Pharmaceuticals:\n\n**Purpose:** The Development Agreement aims to facilitate the development and commercialization of anti-viral pharmaceutical products by WPD Pharmaceuticals, with CNS Pharmaceuticals, Inc. providing funding in exchange for economic rights.\n\n**Obligations:**\n\n* WPD Pharmaceuticals is obligated to use commercially reasonable efforts to develop and commercialize the Development Products, with a goal of eventual approval in the Development Territory.\n* CNS Pharmaceuticals, Inc. is obligated to fund a portion of the development costs in exchange for Development Fees, which are 50% of Net Sales for Development Products in the Development Territory.\n\n**Risks:** The agreement involves risks for both parties, including the uncertainty of regulatory approval, the potential for delays or failures in development, and the risk of financial losses if the Development Products do not meet expectations.",
    "termination": "6.2 Subject to any rights herein which survive termination, this Agreement will earlier terminate in its entirety: (i) upon thirty (30) calendar\ndays written notice from either party if the other party materially breaches this Agreement, unless before the end of such thirty (30) calendar day\nnotice period, the breaching party has cured the material default or breach to the non-breaching party’s reasonable satisfaction; or (ii) at any time\nby mutual written agreement between the Parties, subject to any terms herein which survive termination.",
    "confidentiality": "\"Confidential Information” includes: (1) all information contained in documents marked \"confidential\" and disclosed by one Party (the \"disclosing party\") to the other Party (the \"recipient party\") pursuant to this Agreement; (2) orally disclosed information which is disclosed by the disclosing party to the recipient party pursuant to this Agreement, summarized in writing, identified as \"confidential\" and delivered to the recipient party; and (3) all proprietary technical information, business and financial information, and all other information which a reasonable person would treat confidentially that relates to the Development Products and disclosed from the disclosing party to the recipient party, whether or not the information is marked as “confidential.”",
    "liability": "\"\"To WPD’s knowledge, WPD and its subsidiaries (if any) have been and currently are in material compliance with the GDPR. To ensure material compliance with the Privacy Laws, WPD and its subsidiaries (if any) have taken, and currently take, commercially reasonable steps reasonably designed to ensure compliance in all material respects with Privacy Laws relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data that WPD has collected, and collects, or is in WPD’s possession or will be in WPD’s possession during the Term.\"\""
  },
  {
    "contract_id": "CoherusBiosciencesInc_20200227_10-K_EX-10.29_12021376_EX-10.29_Development Agreement",
    "summary": "Here is a 100-150 word summary of the License and Development Agreement between Bioeq IP AG and Coherus BioSciences, Inc.:\n\n**Purpose:** The agreement grants Coherus BioSciences, Inc. an exclusive license from Bioeq IP AG to commercialize Ranibizumab biosimilar products in the United States.\n\n**Obligations:**\n\n* Bioeq IP AG: Grants an exclusive license, provides initial development and manufacturing plans, and makes upfront, milestone, and royalty payments to Coherus BioSciences, Inc.\n* Coherus BioSciences, Inc.: Pays upfront, milestone, and royalty payments to Bioeq IP AG, develops and commercializes Ranibizumab biosimilar products, and complies with regulatory requirements.\n\n**Risks:** The agreement involves significant financial obligations, regulatory risks, and intellectual property risks, including the potential for patent disputes and competition from other biosimilar products.",
    "termination": "\"\"\"\"TERMINATION; NON-SOLICITATION37\n16. GENERAL PROVISIONS43\"\"\"",
    "confidentiality": "11. CONFIDENTIALITY30",
    "liability": "\"\"\"\"LIABILITY34\n14. GOVERNANCE35\n15. TERM AND TERMINATION; NON-SOLICITATION37\n16. GENERAL PROVISIONS43\"\""
  },
  {
    "contract_id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Development Agreement between Stryker and Conformis:\n\n**Purpose:** The Development Agreement aims to facilitate the development of Patient-Specific Instrumentation (KIB Product) by Conformis for use with Stryker's Off-The-Shelf Knee Implant, Triathlon.\n\n**Obligations:**\n\n* Stryker: Provide Conformis with necessary resources and support to develop the KIB Product.\n* Conformis: Develop the KIB Product in accordance with the R&D Program and deliver it to Stryker.\n\n**Risks:** Both parties assume risks related to the development and commercialization of the KIB Product, including potential intellectual property disputes, regulatory compliance issues, and commercial performance risks. Conformis also indemnifies Stryker against certain claims related to the KIB Product. The agreement outlines specific obligations and responsibilities for both parties, including confidentiality, intellectual property protection, and dispute resolution mechanisms.",
    "termination": "\"\"The R&D Work Plan may be amended by mutual written agreement of the Parties from time to time.\"\"",
    "confidentiality": "\"\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement.\"",
    "liability": "liability in the event of any such rejection or failure by Conformis to deliver materially conforming Deliverables hereunder so long as such rejection or failure does not arise from Conformis’ fraud, willful misconduct, gross negligence or bad faith."
  },
  {
    "contract_id": "CreditcardscomInc_20070810_S-1_EX-10.33_362297_EX-10.33_Affiliate Agreement",
    "summary": "Here is a 100-150 word summary of the Chase Affiliate Agreement:\n\n**Purpose:** The Chase Affiliate Agreement is a contract between Chase Bank USA, N.A. (Chase) and an Affiliate (you) to participate in the Chase Affiliate Program. The purpose is to establish a partnership where the Affiliate promotes Chase's credit card products and services through their website, and Chase pays the Affiliate a fee for each approved credit card account that originates from the Affiliate's website.\n\n**Obligations:** The Affiliate must submit a complete registration form and agree to the terms and conditions of the agreement. Chase will evaluate the registration form and notify the Affiliate of acceptance or rejection. The Affiliate must ensure their website does not contain Restricted Content, which includes prohibited images, content, and activities. Chase reserves the right to terminate the agreement if the Affiliate's website is deemed unsuitable.\n\n**Risks:** The Affiliate risks having their registration form rejected or their agreement terminated if their website contains Restricted Content or is deemed unsuitable. Additionally, the Affiliate may be liable for any intellectual property rights violations or other prohibited activities.",
    "termination": "Chase also reserves the right to terminate this Agreement in the event that any Restricted Content is incorporated on Affiliate’s site after \nacceptance of your registration form and the commencement of the term of this Agreement. Chase may also terminate this Agreement if your site is \ndeemed unsuitable based on the criteria below:",
    "confidentiality": "\"Except as otherwise provided in this Agreement or with the consent of the other party hereto, each of the parties hereto agrees that all information\nincluding, without limitation, the terms of this Agreement, business and financial information, customer and vendor lists, and pricing and sales\ninformation, concerning Chase, Customer or Affiliate shall remain strictly confidential and secret and shall not be utilized, directly or indirectly, by\nsuch party for its own business purposes or for any other purpose except and solely to the extent necessary to exercise rights and perform\nobligations under this Agreement. The foregoing restrictions will not apply to information to the extent it (i) was known to the receiving party at the\ntime of disclosure; (ii) has become publicly known through no wrongful act of the receiving party; (iii) has been rightfully received from a third\nparty under no obligation to the disclosing party; (iv) has been disclosed by court order or as otherwise required by law if the receiving party has\ngiven the disclosing party a reasonable opportunity to contest or limit the scope of such required disclosure.\"",
    "liability": "\"liabilities, damages or expenses (including attorneys’ fees and costs) of any nature whatsoever incurred or suffered by Chase (collectively the “losses”), in so far as such losses (or actions in respect thereof) arise out of, are related to, or are based on (i) the breach of any representation, warranty, or covenant made by Affiliate herein; or (ii) any claim related to Affiliate’s site.\""
  },
  {
    "contract_id": "CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement",
    "summary": "Here is a 100-150 word summary of the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc., including purpose, obligations, and risks:\n\n**Purpose:** The Marketing Affiliate Agreement aims to formalize the prior verbal understandings between the parties regarding the marketing and support of the Technology, a distribution of rights to certain technology and content.\n\n**Obligations:**\n\n* Birch First Global Investments Inc. (Company) grants Mount Knowledge Holdings Inc. (MA) the right to market and sell the Technology to corporate users, government agencies, and educational facilities.\n* MA agrees to use its best efforts to market and license the Technology, execute a Company License Agreement with clients, and provide customer and technical support.\n* Both parties acknowledge their obligations to protect copyrights, trademarks, and other proprietary rights.\n\n**Risks:** The agreement poses risks for both parties, including potential infringement of third-party rights, liability for customer support, and the need to comply with local laws and regulations.",
    "termination": "\"\"\"\"termination provisions contained in paragraph 18 of this Agreement.\"\"\"",
    "confidentiality": "\"MA agrees not to remove or alter in any manner any copyright, trademark or other proprietary notices contained in the Technology.\"",
    "liability": "\"\"MA will notify Company immediately in the event that it is unable to respond effectively to any end users’ requests.\"\""
  },
  {
    "contract_id": "DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding and Services Agreement between PrimeCall and DeltaThree:\n\n**Purpose:** The agreement aims to co-brand a prepaid IP telephony calling card, allowing both parties to benefit from each other's services and expertise. PrimeCall will provide DeltaThree with services such as printing of calling cards, toll-free access numbers, and pricing and marketing services.\n\n**Obligations:** PrimeCall is obligated to negotiate and source printing of calling cards, procure a toll-free access number, and provide pricing and marketing services. DeltaThree is obligated to reimburse PrimeCall for costs incurred in connection with the manufacturing and printing of calling cards and to use its reasonable best efforts to increase the percentage of traffic derived from the use of the calling card carried via the DeltaThree Network.\n\n**Risks:** The agreement poses risks for both parties, including the potential for termination of the agreement if PrimeCall's ownership stake in DeltaThree falls below 50%. Additionally, DeltaThree may face risks related to the quality and standards of PrimeCall's services, and PrimeCall may face risks related to the costs and responsibilities associated with providing services to DeltaThree.",
    "termination": "Section 6.01 [Termination for Cause]. Termination for Cause. In the event that either PrimeCall or DeltaThree materially breaches any of its duties or obligations hereunder, which breach shall not be cured within thirty (30) days after written notice is given to the breaching party specifying the breach, then either PrimeCall or DeltaThree, as the case may be, may, by giving written notice thereof to the other, terminate this Agreement as of a date specified in such notice of termination, which date shall be no earlier than ten (10) days after the date of such notice.\n\nSection 6.02 [Termination for Bankruptcy]. Termination for Bankruptcy. In the event of the Bankruptcy (as hereinafter defined) of either PrimeCall or DeltaThree, then the non-bankrupt party may, by written notice thereof to the party in Bankruptcy, terminate this Agreement as of a date specified in such notice of termination, which date shall be no earlier than ten (10) days after the date of such notice.",
    "confidentiality": "Section 8.01 [Confidentiality]. Confidentiality. PrimeCall and DeltaThree each agree that\nfor the longest period permitted by law each shall hold in strictest confidence\nand, without the prior written approval of the other party hereto, not to use\nfor their own benefit or the benefit of any party other than the other party\nhereto, or disclose to any person, firm or corporation other than such party\n(other than as required by law) any confidential proprietary information\nconcerning the business and affairs of the other party hereto; provided,\nhowever, that the foregoing limitations and restrictions shall not apply to\ninformation that (i) is or becomes generally available to the public other than\nas a result of a disclosure by the directors, officers, shareholders, partners,\naffiliates, employees, agents or advisors of PrimeCall or DeltaThree, as the\ncase may be, or (ii) is or becomes available to PrimeCall or DeltaThree on a\nnon-confidential basis from a source other than the other party hereto or any of\nits advisors, agents or affiliates, provided that such source is not known by\nPrimeCall or DeltaThree, as the case may be, to be bound by a confidentiality\nagreement with or other obligation of secrecy to the other party hereto. Each of\nPrimeCall and DeltaThree recognize that the absence of a time limitation in this\nSection 8.01 [Confidentiality] is reasonable and properly required for the protection of the other\nparty hereto and in the event that the absence of such limitation is deemed to\nbe unreasonable by a court of competent jurisdiction, PrimeCall and DeltaThree\neach agree and submit to the imposition of such a limitation as said court shall\ndeem reasonable.",
    "liability": "IN NO EVENT SHALL DELTATHREE BE LIABLE TO PRIMECALL FOR ANY SPECIAL, INCIDENTIAL OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, LOSS OF PROFITS, REVENUES OR DATA WHETHER BASED ON BREACH OF CONTRACT, TORT OR OTHERWISE, WHETHER OR NOT PRIMECALL HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE."
  },
  {
    "contract_id": "DigitalCinemaDestinationsCorp_20111220_S-1_EX-10.10_7346719_EX-10.10_Affiliate Agreement",
    "summary": "Here is a 100-150 word summary of the Network Affiliate Agreement between National CineMedia, LLC (NCM) and Digital Cinema Destinations Corp. (Network Affiliate):\n\n**Purpose:** The agreement aims to establish a strategic alliance between NCM and Network Affiliate to expand NCM's advertising footprint in the markets served by Network Affiliate.\n\n**Obligations:**\n\n* NCM will provide the Digital Content Network and advertising services to Network Affiliate.\n* Network Affiliate will accept and display the services in its theatres.\n* Both parties will maintain confidentiality and protect each other's confidential information.\n\n**Risks:** The agreement involves risks for both parties, including the potential for revenue losses or gains, changes in market conditions, and the need to maintain confidentiality and protect each other's intellectual property.",
    "termination": "\"termination of the Agreement for any\nreason, Network Affiliate shall pay NCM the value of the NCM Equipment, if any, that remains on NCM’s financial statements as of the time of\nsuch expiration or termination. Upon payment of such amount to NCM by Network Affiliate at the time of such expiration or termination, NCM’s\nownership interest in the NCM Equipment will transfer to Network Affiliate.\"",
    "confidentiality": "\"Confidential Information” means any and all technical and non-technical information of or related to either Party, including, without limitation, proprietary information, know-how, the NCM Property and Derived Works, and information related to or regarding either Party’s research and development, finances, suppliers, customers, business forecasts, and marketing plans, in whatever form disclosed or made available.",
    "liability": "\"\"NOW, THEREFORE, in consideration of the premises and mutual covenants in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby expressly acknowledged, and, intending to be legally bound hereby, the Parties agree as follows:\"\""
  },
  {
    "contract_id": "EbixInc_20010515_10-Q_EX-10.3_4049767_EX-10.3_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding Agreement between About.com, Inc. and ebix.com, Inc., including purpose, obligations, and risks:\n\n**Purpose:** The Co-Branding Agreement aims to create an independent co-branded channel on About.com's network, allowing visitors to access insurance information and promoting ebix.com's Insurance Center and ebix Site.\n\n**Obligations:**\n\n* About.com will provide a co-branded channel on its network, featuring ebix.com's content and promoting ebix.com's Insurance Center and ebix Site.\n* ebix.com will provide content for the co-branded channel and receive promotions on About.com's network.\n* Both parties will share customer data and usage information, subject to confidentiality and data protection obligations.\n\n**Risks:** The agreement involves sharing sensitive customer data and usage information, which may pose risks to both parties' data security and confidentiality. Additionally, the agreement's terms and conditions may be subject to change, potentially affecting the parties' obligations and liabilities.",
    "termination": "\"[TERMINATION AND SURVIVAL].\"",
    "confidentiality": "\"\"Confidential treatment has been requested for portions of this document.\nThe redacted material has been filed with the commission pursuant to an\napplication for confidential treatment.\"\"",
    "liability": "About will defend, indemnify and hold ebix, its officers, directors, agents, employees and consultants (collectively the \"eBix Indemnified Parties\") harmless from and against any third party claims against ebix for all liabilities, claims, actions, damages, losses, settlements, and costs, and expenses (including, without limitation reasonable attorneys' fees) relating to or arising out of About's breach of its warranties, representations, responsibilities or covenants hereunder."
  },
  {
    "contract_id": "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc.:\n\n**Purpose:** The purpose of this agreement is to establish a custom, category-exclusive, co-branded center on Women.com's website, featuring eDiets' content, to promote the eDiets brand and drive traffic to the eDiets website.\n\n**Obligations:**\n\n* Women.com will create a dedicated area on their website, branded with the eDiets logo, and provide links to the Diet Center on their Fitness, Health, and Food channels.\n* eDiets will provide content, branding, and other identification to Women.com for use on the Diet Center.\n* Both parties will work together to design, develop, and maintain the Diet Center.\n\n**Risks:** The agreement includes a provision that allows eDiets to remove back buttons to the Women.com website if they believe it has a negative effect on user registration and conversion rates. Additionally, each party will bear their own expenses related to their responsibilities under the agreement.",
    "termination": "\"termination for all pre-paid\nimpressions or other promotions not delivered as of the date of termination.\"",
    "confidentiality": "11. CONFIDENTIALITY.\n11.1 The parties acknowledge that, in the course of performing duties\nunder this Agreement, each party may obtain Confidential Information from the\nother party. For the purposes of this Section 11, the party disclosing\nConfidential Information shall be the \"Disclosing Party\" and the party receiving\nConfidential Information shall be the \"Receiving Party\".",
    "liability": "Women.com agrees to indemnify, defend and forever hold harmless the eDiets Indemnitees from and against all Indemnifiable Sums arising out of third party claims to the extent such claims are based upon: (a) content published on the Women.com Sites, other than eDiets Content; (b) the operation of the Women.com membership program; or (c) any product or service, other than a product or service provided by eDiets, sold, licensed or otherwise made available on the Women.com Sites.\n\neDiets agrees to indemnify, defend and forever hold harmless the Women.com Indemnitees from and against all Indemnifiable Sums arising out of third party claims to the extent such claims are based upon: (a) content published on the eDiets Sites, other than Women.com Content; (b) tools used on or in connection with the eDiets Site, including, but not limited to the Diet Tool; (c) the operation of the eDiets membership program; (d) any product or service sold, licensed or otherwise made available on any eDiets Site; or (e) any product or service sold, licensed or made available by eDiets on the Diet Center."
  },
  {
    "contract_id": "ElPolloLocoHoldingsInc_20200306_10-K_EX-10.16_12041700_EX-10.16_Development Agreement",
    "summary": "Here is a 100-150 word summary of the EL POLLO LOCO FRANCHISE DEVELOPMENT AGREEMENT:\n\n**Purpose:** The purpose of this agreement is to grant the Developer exclusive or non-exclusive development rights to establish and operate El Pollo Loco restaurants within a specified Territory.\n\n**Obligations:**\n\n* **Franchisor (El Pollo Loco):** Grants development rights to the Developer, provides the El Pollo Loco System, and is responsible for insurance and indemnification.\n* **Developer:** Represents that it is experienced in the restaurant business, has independent knowledge of the nature and specifics of the restaurant business, and is responsible for operating the El Pollo Loco restaurants in accordance with the El Pollo Loco System.\n\n**Risks:** The Developer assumes the risk of operating the El Pollo Loco restaurants, including the risk of financial loss, and is subject to termination of the agreement if it fails to meet its obligations. The Franchisor also assumes the risk of potential conflicts with other El Pollo Loco restaurants in the Territory.",
    "termination": "12.EFFECT OF TERMINATION. 16",
    "confidentiality": "\"\"\"Developer, therefore, agrees that if it should engage in any such unauthorized or improper use during, or after, the term of this Agreement, Franchisor shall be entitled to both seek temporary and permanent injunctive relief from any court of competent jurisdiction in addition to any other remedies prescribed by law.\"\"\"",
    "liability": "Franchisor shall have no obligation to assist Developer to negotiate its leases."
  },
  {
    "contract_id": "EmbarkComInc_19991008_S-1A_EX-10.10_6487661_EX-10.10_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding Agreement between Snap Technologies, Inc. and United Airlines, Inc.:\n\n**Purpose:** The Co-Branding Agreement aims to establish a partnership between Snap and United Airlines to co-brand their respective web sites, with the goal of promoting college and graduate degree programs to end-users.\n\n**Obligations:** Snap is obligated to provide access to its web site and certain information about its end-users, while United Airlines is required to obtain sponsorship placement on Snap's web site and provide content for the co-branded pages. Both parties must also protect each other's confidential information and intellectual property rights.\n\n**Risks:** The agreement poses risks for both parties, including the potential for unauthorized use of confidential information, intellectual property infringement, and reputational damage if the co-branded pages are not properly maintained. Additionally, the agreement may expose Snap to liability for any content provided by United Airlines.",
    "termination": "4.2 TERMINATION. Either party may terminate the Term upon not less than sixty (60) days prior written notice to the other party of any breach hereof by such other party. In addition, either party may terminate the Term immediately upon written notice in the event that the other party shall fail to do business in the normal course or become subject to any bankruptcy, assignment for creditors, corporate dissolution or similar proceeding.",
    "confidentiality": "\"CONFIDENTIAL INFORMATION\" means information of either party (whether of a technical, business or other nature) which the other party knows or reasonably should know to be confidential or proprietary information of such party.",
    "liability": "Neither Party makes any other representations or warranties of any kind, express or implied, in connection with this Agreement or the transactions contemplated hereby."
  },
  {
    "contract_id": "EmeraldHealthBioceuticalsInc_20200218_1-A_EX1A-6 MAT CTRCT_11987205_EX1A-6 MAT CTRCT_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Consulting and Product Development Agreement:\n\n**Purpose:** The agreement outlines the responsibilities and obligations of Emerald Health Sciences Inc. (EHS), Emerald Health Nutraceuticals Inc. (EHN), and Michael T. Murray, N.D. (Dr. Murray) in developing and marketing pharmaceutical products.\n\n**Obligations:**\n\n* EHS and EHN will bear all costs associated with product development, sales, and marketing.\n* Dr. Murray will provide ongoing services to EHS and EHN, including guidance on product development, scientific validation, and marketing.\n* EHN will pay Dr. Murray $8,333 per month and grant him options to purchase EHS common stock.\n* Dr. Murray will receive royalties on net sales of products developed for EHN.\n\n**Risks:** The agreement poses risks for Dr. Murray, including the potential for financial losses if EHN's products do not perform well in the market. Additionally, Dr. Murray's 5% equity ownership in EHN may be diluted if EHN issues additional shares.",
    "termination": "6.2 Termination\nEHS or EHN, on the one hand, and Dr. Murray, on the other, may terminate any Services Term of this Agreement by delivering 60 days\nwritten notice to the other party. Notwithstanding the foregoing, EHS or EHN may immediately terminate the Services Term without notice\nshould Dr. Murray be in breach of this Agreement.",
    "confidentiality": "Neither EHS, EHN nor Dr. Murray shall disclose to any third parties, except as required by law, at any time during or subsequent to the term of this Agreement, any Confidential Information.",
    "liability": "\"\"\"\"ARTICLE 4 -- LIMITATION OF LIABILITY\n\n4.1 Neither EHS, EHN, nor Dr. Murray shall be liable for any indirect, special, incidental, consequential, or punitive damages\narising out of or related to this Agreement, including but not limited to, loss of profits, loss of business, or interruption of business,\neven if any of them have been advised of the possibility of such damages. The liability of EHS, EHN, and Dr. Murray to each other\nand to third parties for damages arising out of or related to this Agreement shall be limited to the amount of $100,000.00. The\nforegoing limitation of liability shall apply to any and all claims, demands, or causes of action arising out of or related to this\nAgreement, whether based on contract, tort, or any other theory of liability. The parties acknowledge that the limitation of liability\nset forth in this Section 4.1 is a material term of this Agreement and that without such limitation, they would not have entered into\nthis Agreement. The parties agree that the limitation of liability set forth in this Section 4.1 is a reasonable limitation of liability\nunder the circumstances and that it is a fair and equitable allocation of risk between the parties. The limitation of liability set\nforth in this Section 4.1 shall survive the expiration or termination of this Agreement, regardless of the cause or reason\ntherefor. \"\"\""
  },
  {
    "contract_id": "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement",
    "summary": "Here is a 100-150 word summary of the contract, including purpose, obligations, and risks:\n\n**Purpose:** This Exclusive License and Product Development Agreement is entered into between Eton Pharmaceuticals, Inc. (ETON) and Aucta Pharmaceuticals, Inc. (Aucta) on June 12, 2019. The purpose of the agreement is to grant ETON an exclusive license to develop, market, and sell pharmaceutical drug products, known as the \"Products,\" in a specified territory.\n\n**Obligations:** ETON is obligated to pay Aucta certain milestone, royalty, and licensing payments based on the sale of Products in the territory. Aucta is obligated to grant ETON an exclusive license to the Products, Dossiers, and Aucta Background Intellectual Property. Both parties are also obligated to comply with applicable laws and regulations.\n\n**Risks:** The agreement involves risks for both parties, including the potential for disputes over intellectual property, regulatory compliance issues, and financial risks associated with the development and commercialization of the Products.",
    "termination": "\"\"\"If the foregoing reconciliation report shows either an underpayment or an overpayment between the Parties, the Party owing payment to\nthe other Party shall pay the amount of the difference to the other Party within thirty (30) days after the date of delivery of such report.\"\"\"",
    "confidentiality": "\"1.10 “Confidential Information” shall have the meaning ascribed to the\"",
    "liability": "\"\"liability however arising, whether present, unascertained, immediate, future or contingent, whether based in contract,\ntort or statute and whether involving a Third Party or a Party or otherwise.\"\""
  },
  {
    "contract_id": "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Joint Development Agreement between FuelCell Energy, Inc. (FCE) and ExxonMobil Research and Engineering Company:\n\n**Purpose:** The agreement aims to facilitate collaborative research and development of Molten Carbonate Fuel Cells (MCFCs) to reduce carbon dioxide emissions from industrial and power sources.\n\n**Obligations:** Both parties are obligated to work together on mutually agreed-upon projects, with FCE responsible for conducting work using Generation 1 and 2 technologies, subject to ExxonMobil's approval. ExxonMobil has the right to change its Steering Committee members and provide administrative guidance for the program. FCE is also required to disclose and maintain confidentiality of program results and background information.\n\n**Risks:** The agreement outlines potential risks, including infringement of third-party patents, payment obligations, and termination of the agreement due to non-compliance or force majeure events. Disputes will be resolved through arbitration, and the agreement will be governed by the laws of the State of Delaware.",
    "termination": "\"\"ARTICLE 15 - FORCE MAJEURE 18\"\"",
    "confidentiality": "\"\"\"\"CONFIDENTIALITY AND RESTRICTED USE 3\"\"",
    "liability": "\"\"ARTICLE 15 - FORCE MAJEURE 18\"\""
  },
  {
    "contract_id": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement_Option Agreement",
    "summary": "Here is a 100-150 word summary of the Development and Option Agreement between Harpoon Therapeutics, Inc. and AbbVie Biotechnology Ltd, including purpose, obligations, and risks:\n\n**Purpose:** The Development and Option Agreement aims to facilitate the development and commercialization of a licensed compound or product by AbbVie, with Harpoon retaining rights and interests.\n\n**Obligations:**\n\n* Harpoon: Provide the licensed compound or product for development and commercialization, maintain confidentiality, and perform regulatory and pharmacovigilance obligations.\n* AbbVie: Exercise options to develop and commercialize the licensed compound or product, make payments and royalties to Harpoon, and maintain confidentiality.\n\n**Risks:** The agreement involves significant risks for both parties, including potential losses due to regulatory or commercial failures, intellectual property disputes, and reputational damage. Additionally, the agreement's complexity and scope may lead to disputes and litigation.",
    "termination": "12.6 Termination in Entirety. 63",
    "confidentiality": "\"\"Confidential\nEXECUTION COPY\nCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY\nHARMFUL IF PUBLICLY DISCLOSED.\"\"",
    "liability": "\"\"\"\"partnership, corporation, limited liability company, business trust, joint stock company, trust, unincorporated association, joint venture or\nother similar entity or organization, including a government or political subdivision, department or agency of a government.\"\"\""
  },
  {
    "contract_id": "HealthcentralCom_19991108_S-1A_EX-10.27_6623292_EX-10.27_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding Content Agreement between MediaLinx Interactive, L.P. (MLX) and HealthCentral.com Inc. (HCI):\n\n**Purpose:** The agreement aims to co-brand content from HCI's health services web site (healthcentral.com) with MLX's Internet services, specifically the \"Sympatico\" web site, to mutually develop and integrate content.\n\n**Obligations:**\n\n* MLX will technically host and moderate HealthyWay discussion forums, promote the Co-Branded Site, and grant HCI a non-exclusive right to use MLX images and content.\n* HCI will use MLX logos and trademarks in accordance with MLX's guidelines and ensure compliance with applicable laws and regulations.\n\n**Risks:** The agreement involves risks for both parties, including potential liability for transactions and products hosted on the Co-Branded Site, and the need for MLX to ensure user traffic levels meet agreed-upon targets.",
    "termination": "11.2 Termination\n(a) Either Party may terminate this Agreement upon 30 days prior written notice\nto the other Party if 1) such other Party breaches any material term of\nthis Agreement, unless such breach is cured within 30 days; or 2) if any of\nthe terms of this Agreement that require mutual approval are not mutually\nagreed to;\n\n(b) This Agreement may be terminated by a Party immediately, without notice:\n(i) upon the institution by or against the other Party of insolvency,\nreceivership, or bankruptcy proceedings or any other proceedings\nfor the settlement of the other Party's debts, if such proceedings\nare not dismissed within sixty (60) days;\n(ii) upon the other Party making an assignment for the benefit of\ncreditors; or\n(iii) upon the other Party's dissolution;\n\n(c) Either party may terminate this Agreement upon 30 days written notice if\neither Party's corporate structure has undergone a material ownership\nchange such that its corporate interests are then in conflict with the\ncorporate interests of the other Party; and\n\n(d) Upon termination or expiration of this Agreement for any reason:\n(i) the Parties shall immediately cease using the Marks of the other\nParty;\n(ii) the Parties shall immediately return to each other all property of\nthe other and cease using or distributing all advertising or\npromotional materials, if any, containing references to the other\nParty or the other Party's product;\n(iii) the Parties shall remove all special links made pursuant to this\nAgreement from their respective products of the other Party; and\n(iv) each Party shall pay to the other Party all outstanding amounts\nwhich have accrued",
    "confidentiality": "\"\"CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO\nTHE OMITTED PORTIONS.\"\"",
    "liability": "\"Without limiting the generality of the foregoing, HCI shall use all reasonable commercial efforts to: 1) ensure that the hosting services provided in connection with the Co-Branded Site are provided at the same standard as the hosting of the Sympatico web site, and 2) ensure that the Co-Branded Site is available 7 days per week and 24 hours per day;\""
  },
  {
    "contract_id": "HfEnterprisesInc_20191223_S-1_EX-10.22_11931299_EX-10.22_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Outsource Technology Development Agreement:\n\n**Purpose:** The purpose of this agreement is for Document Security Systems, Inc. (DSS) to outsource technology development to HotApp International Ltd. (Developer) to develop an Android software application for DSS's AuthentiGuard Technology suite.\n\n**Obligations:**\n\n* DSS grants Developer a non-exclusive, limited, and non-transferable license to develop the Improvements to the Technology.\n* DSS pays Developer $23,000 per month for the duration of the Term.\n* Developer is responsible for satisfactory performance of the services set forth in Schedule 1.\n* Developer acknowledges DSS's ownership of the Technology, Improvements, and Intellectual Property.\n\n**Risks:** If Developer breaches DSS's Technology or Intellectual Property rights, DSS may terminate the agreement immediately. Additionally, if Developer declares bankruptcy or reorganizes under a bankruptcy act, DSS may terminate the agreement. Upon termination, Developer must cease use of proprietary technology files and deliver all proprietary files and Improvements to DSS.",
    "termination": "2.2. Early Termination.\n2.2.1. Either party may terminate this Agreement prior to expiration of the Term: (i) upon thirty (30) days prior written notice, or\n(ii) immediately upon written notice to the other party if: (a) the other party declares or a petition is filed in any court for insolvency or bankruptcy\nand such petition is not dismissed in thirty (30) days; (b) the other party reorganizes under the relevant bankruptcy act or any similar statute in\nsuch party’s jurisdiction of incorporation; (c) the other party consents to the appointment of a trustee in bankruptcy or a receiver or similar entity;\nor (d) the Developer breaches DSS’s Technology or Intellectual Property rights contained herein.\n2.2.2. Upon the expiration or termination of this Agreement, (i) the Technology Development Services License granted to\nDeveloper hereunder shall immediately cease, and (ii) Developer shall immediately cease use of all proprietary technology files heretofore delivered\nby DSS and shall deliver to DSS all such proprietary files along with any and all Improvements completed to date by Developer.",
    "confidentiality": "During the Term of this Agreement and thereafter for a period of five (5) years, the parties shall be bound by all of the protective terms and conditions of the NDA.",
    "liability": "\"\"The parties acknowledge that they have entered into that certain Mutual Non-Disclosure Agreement dated as of January 18, 2018 (the “NDA”), a copy of which is attached hereto as Exhibit A. The terms of the NDA shall be deemed to be incorporated by reference into this Agreement, mutatis mutandis. During the Term of this Agreement and thereafter for a period of five (5) years, the parties shall be bound by all of the protective terms of the NDA, and neither party shall disclose to any liability company, association, trust or any other entity or organization of any kind or character, including a governmental authority or agency, any Confidential Information (as defined in the NDA) without the prior written consent of the other party.\""
  },
  {
    "contract_id": "IbioInc_20200313_8-K_EX-10.1_12052678_EX-10.1_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Master Joint Development Agreement between iBio Inc. and Beijing CC-Pharming Ltd.:\n\n**Purpose:** The agreement aims to establish a long-term working relationship between iBio and CC-Pharming for joint research and development projects related to biopharmaceuticals, leveraging iBio's proprietary technology and expertise.\n\n**Obligations:**\n\n* iBio grants CC-Pharming a non-exclusive license to use its technology for product development and production in China.\n* iBio will work with CC-Pharming to perform a manufacturing development program and provide technical information, know-how, and services.\n* CC-Pharming will acknowledge the proprietary nature of iBio's technology and maintain confidentiality.\n\n**Risks:** The agreement involves risks for both parties, including the potential for intellectual property disputes, technology transfer challenges, and commercial risks associated with product development and sales in China.",
    "termination": "6.3 If either Party to this Agreement fails to perform or violates any material obligation of this Agreement, then, upon thirty (30) days written\nnotice to the breaching Party specifying such failure or violation, the non-breaching Party may terminate this Agreement without liability,\nunless: (a) the failure or violation specified in the default notice has been cured within the thirty (30) day notice period; or (b) the failure or\nviolation reasonably requires more than thirty (30) days to correct, and the breaching Party has begun substantial corrective action to\nremedy the failure or violation within the thirty (30) day notice period and diligently pursues such action, in which event, termination shall\nnot be effective unless sixty (60) days has expired from the date of the default notice without such corrective action being completed and\nthe failure or violation remedied.",
    "confidentiality": "\"\"\"confidential and proprietary nature of iBio’s Technology and\ntechnical information, know-how, documents, materials, software, vectors, constructs, trade secrets, and other valuable business or\nscientific information that iBio will share with CC-Pharming in order to fulfill the purpose of this Agreement, namely, to form a legal\nstructure for a collaborative business venture in which CC-Pharming and iBio shall share revenue from product sales.\"\"\"",
    "liability": "\"unless: (a) the failure or violation specified in the default notice has been cured within the thirty (30) day notice period; or (b) the failure or\nviolation reasonably requires more than thirty (30) days to correct, and the breaching Party has begun substantial corrective action to\nremedy the failure or violation within the thirty (30) day notice period and diligently pursues such action, in which event, termination shall\nnot be effective unless sixty (60) days has expired from the date of the default notice without such corrective action being completed and\nthe failure or violation remedied.\""
  },
  {
    "contract_id": "ImpresseCorp_20000322_S-1A_EX-10.11_5199234_EX-10.11_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding Agreement between VerticalNet and Impresse:\n\n**Purpose:** The Co-Branding Agreement aims to create a Co-Branded Site where users can access Impresse's commercial printing services and promote the site on VerticalNet's online communities.\n\n**Obligations:**\n\n* VerticalNet is responsible for providing a designated area for banner advertisements and ensuring the Co-Branded Site is fully operational by the Launch Date.\n* Impresse must provide its commercial printing services and ensure the Co-Branded Content is accurate and up-to-date.\n* Both parties must maintain confidentiality of each other's proprietary information and intellectual property.\n\n**Risks:** Failure to meet obligations may result in financial losses, damage to reputation, and potential lawsuits for breach of contract or intellectual property infringement. Additionally, the agreement's confidentiality provisions may limit the parties' ability to disclose information to third parties, potentially hindering business relationships or future collaborations.",
    "termination": "\"\"\"]TERMINATION AND RENEWAL]\"\"\"",
    "confidentiality": "\"\"\"\"Confidential Treatment Requested]\" is not a confidentiality clause.",
    "liability": "9.3. LIMITATION OF LIABILITY. EXCEPT IN CONNECTION WITH A BREACH BY EITHER PARTY OF ARTICLE 7 OR SECTION 8.1.5 [REPRESENTATIONS AND WARRANTIES] (v) AND THE INDEMNIFICATION OBLIGATIONS OF IMPRESSE UNDER SECTION 9.4(i)(d) [INDEMNIFICATION BY IMPRESSE] AND THE INDEMNIFICATION OBLIGATIONS OF VERTICALNET UNDER SECTION 9.5(i)(d) [INDEMNIFICATION BY VERTICALNET], NEITHER PARTY WILL BE LIABLE FOR ANY SPECIAL, INDIRECT, CONSEQUENTIAL, EXEMPLARY OR INCIDENTAL DAMAGES ARISING OUT OF OR RELATED TO THIS AGREEMENT, HOWEVER CAUSED AND UNDER ANY THEORY OF"
  },
  {
    "contract_id": "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc.:\n\n**Purpose:** The agreement aims to produce a series of recorded compilations and companion song books featuring praise and worship repertoires, co-branded and co-marketed worldwide under the \"Songs 4 Worship\" series.\n\n**Obligations:**\n\n* Integrity Incorporated will obtain master lease and print agreements with third-party owners, manufacture the product, and sell to Time Life its requirements for resale.\n* Time Life, Inc. will create artwork for product covers and packaging, pay mastering expenses, and hold exclusive worldwide rights to promote and sell the product through various distribution channels.\n\n**Risks:** The agreement involves shared expenses for additional products created under the \"Songs 4 Worship\" branding, and the parties may face risks related to master, mechanical, and print rights clearance, as well as competition in the market.",
    "termination": "b. If, because of an act of God, inevitable accident, fire, lockout, strike or other labor dispute, riot or civil commotion, act of public enemy, enactment, rule, order or act of any government or governmental instrumentality (whether federal, state, local or foreign), failure of technical facilities, failure or delay of transportation facilities, illness or incapacity of any performer or producer, or other cause of a similar or different nature not reasonably within either party's control, such party is materially hampered in the recording, manufacture, distribution or sale of phonograph records, or its normal business operations become commercially impractical, then without limiting its rights, it will have the option upon notice to suspend the Term of this Agreement for the duration of any such contingency. In the event of a suspension owing to a \"force majeure,\" which suspension exceeds six (6) consecutive months, the non-suspending party may terminate this Agreement upon ten (10) days written notice to other, but only if such \"force majeure\" does not affect a substantial portion of the United States recording industry or the suspension is not lifted by the suspending party within ten (10) days of the receipt of the written notice from the other party.",
    "confidentiality": "\"\"CONFIDENTIAL PORTIONS\n/1/ Indicates information which has been redacted pursuant to a request for\nconfidential treatment.\n2\nINDEX TO THE CONFIDENTIAL PORTIONS\nPAGE SECTION LINE(S)\n---- ------- -------\n1 1(c) 3, 4, and 5\n3 3(a) 4, 5, 10, 11, 12 and 13\n4 4(c) 2, 4 and 5\n4 4(d) 2, 3, 4 and 5\n5 5 2\n3\"\"",
    "liability": "\"liabilities, costs, losses, and expenses (including legal costs and attorneys' fees) arising out of or connected with any claim, demand or action which is inconsistent with any of the warranties, representations, covenants or agreements which the indemnifying party has made in this Agreement. Pending the determination and settlement of any such claim, demand or action, the non-indemnifying party will have the right, at its election, to withhold payment to you of any monies otherwise payable hereunder, in an amount reasonably related to that claim, demand or action, and its estimated costs and expenses (including legal costs and attorneys' fees) in connection therewith.\""
  },
  {
    "contract_id": "InvendaCorp_20000828_S-1A_EX-10.2_2588206_EX-10.2_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the E-CENTIVES - EXCITE@HOME CO-BRANDING AGREEMENT:\n\n**Purpose:** The agreement aims to establish a co-branding partnership between Excite@Home and e-centives, Inc. to distribute e-centives' content through the Excite Network and/or Broadcast Pages, and to promote e-centives on the Excite Network.\n\n**Obligations:**\n\n* Excite@Home will provide e-centives with access to its network and users, and will establish co-branded pages on the e-centives site.\n* e-centives will provide Excite@Home with content, including coupons and offers for products and services.\n* Both parties will work together to promote each other's services and products.\n\n**Risks:** The agreement involves sharing user data and registration information between the parties, which may raise concerns about data privacy and security. Additionally, the agreement may expose both parties to liability for any errors or inaccuracies in the content provided by the other party.",
    "termination": "i) In the event that the Agreement is terminated pursuant to Section\n16.a.v due to e-centives' acquisition by an Excite@Home Named\nCompetitor, or by an entity controlling or controlled by an\nExcite@Home Named Competitor, e-centives shall transfer all of its\nright, title and interest in and to the Payment-Eligible User Data\nto Excite. Notwithstanding the foregoing, Payment-Eligible User Data\nthat relates to users who have opted out in accordance with Section\n5(a) of EXHIBIT D shall continue to be jointly owned by the parties.\n\nii) In the event that the Agreement expires or is terminated for any\nreason other than termination pursuant to Section 16.a.v, the\nparties shall continue to jointly own Payment-Eligible User Data\nin accordance with Section 6.a. The restrictions of Section 6.b\nshall continue to apply, with the exception of subsections 6.b.i\nand 6.b.v.",
    "confidentiality": "\"\"Confidential Treatment has been requested for portions of this agreement.\nThe copy file herewith omits information subject to the confidentiality request.\nOmissions are designated as [*****]. A complete version of this agreement has\nbeen filed separately with the Securities and Exchange Commission.\"\"",
    "liability": "\"\"\"\"Liability), and Section 21 (Dispute Resolution) shall survive any\ntermination or expiration of this Agreement.\"\"\""
  },
  {
    "contract_id": "LeadersonlineInc_20000427_S-1A_EX-10.8_4991089_EX-10.8_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding Agreement between VerticalNet and LeadersOnline:\n\n**Purpose:** The Co-Branding Agreement aims to enable LeadersOnline to advertise its job placement services on VerticalNet's Online Communities through banner ads, newsletters, and employer spotlights, while also granting LeadersOnline access to VerticalNet's proprietary resume bank.\n\n**Obligations:**\n\n* VerticalNet must permit LeadersOnline to advertise its services on VerticalNet's Online Communities and provide access to its proprietary resume bank.\n* LeadersOnline must pay VerticalNet for the advertising services and comply with VerticalNet's terms and conditions.\n* Both parties must maintain confidentiality and protect each other's confidential information.\n\n**Risks:** The agreement poses risks for both parties, including the potential for intellectual property infringement, breach of confidentiality, and financial losses due to non-payment or non-compliance.",
    "termination": "\"\"\"termination of this Agreement. All information contained\nin the Resume Bank shall be handled by LeadersOnline in accordance with\nVerticalNet's standard Privacy Policy as it may be posted on the VerticalNet\nSites from time to time. The foregoing restrictions shall cease to apply from\nand after the time that a Candidate registers through an online form or takes\nother affirmative action to become a member of the LeadersOnline \"Candidate\nCommunity.\"\"\"",
    "confidentiality": "\"\"\"\"confidential information has been omitted from this Exhibit 10.8\n------------\npursuant to a confidential treatment request filed with the Securities and\nExchange Commission. The omitted information is indicated by the symbol \"***\" at\neach place in this Exhibit 10.8 where the omitted information appeared in the\n------------\noriginal.\"\"",
    "liability": "11.3. Limitation of Liability. EXCEPT IN CONNECTION WITH A BREACH BY EITHER"
  },
  {
    "contract_id": "LegacyEducationAllianceInc_20200330_10-K_EX-10.18_12090678_EX-10.18_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Real Estate Education Training Program Development Agreement:\n\n**Purpose:** The agreement is between T&B Seminars, Inc. (T&B) and Legacy Education Alliance Holdings, Inc. (LEA) to develop and operate a \"Tarek's Real Estate 101\" branded seminar style education business that uses Tarek El Moussa's names, images, and likenesses to market and sell real estate investing oriented education products.\n\n**Obligations:** T&B grants LEA the right to use its intellectual property, and LEA agrees to develop and operate the business, market and sell products, and provide T&B with a percentage of the cash sales. Both parties agree to keep confidential information and customer data secret.\n\n**Risks:** The agreement poses risks for both parties, including the potential for competitive harm if the agreement is publicly disclosed, and the risk of financial losses if the business is not successful. Additionally, the agreement requires both parties to comply with confidentiality and non-disclosure obligations, which can be challenging to enforce.",
    "termination": "\"termination not less than 90 days prior to the end of such five-year term; provided, however, T&B shall have the right to terminate the license after the first year of the Term if LEA does not conduct the Business so as to meet the Cash Sales benchmarks set by the parties for years two through five of the Term, as set forth in Section 3.3, below.\"",
    "confidentiality": "\"All information relating to the products or operations of a party, which is provided to the other party, or to which the other party otherwise obtains access, pursuant to, or as a result of, this Agreement shall be treated as Confidential Information hereunder, except such information which the other party can clearly show: (a) at the time of this Agreement is publicly and openly known; (b) after the date of this Agreement becomes publicly and openly known through no fault of the other party; (c) comes into the other party’s possession and lawfully obtained by the other party from a source other than from the party or a source deriving from the party, and not subject to any obligation of confidentiality or restrictions on use; or (d) is approved for release by written authorization of the other party\"",
    "liability": "\"EXCEPT FOR AMOUNTS PAYABLE TO THIRD PARTIES IN CONNECTION WITH CLAIMS SUBJECT TO THE\nINDEMNIFICATION PROVISIONS OF SECTION 9.1 OR A BREACH OF EITHER PARTY’S OBLIGATIONS UNDER SECTION 5\n(CONFIDENTIALITY), NEITHER PARTY WILL, UNDER ANY CIRCUMSTANCES, BE LIABLE TO THE OTHER PARTY FOR ANY LOST PROFITS\nOR ANY OTHER SPECIAL, INDIRECT OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR RELATING TO THIS AGREEMENT EVEN IF\nTHE PARTY HAS BEEN NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES.\""
  },
  {
    "contract_id": "LinkPlusCorp_20050802_8-K_EX-10_3240252_EX-10_Affiliate Agreement",
    "summary": "Here is a 100-150 word summary of the Affiliate Agreement between Link Plus Corporation (LKPL) and Axiometric, LLC:\n\n**Purpose:** The Affiliate Agreement aims to establish a preferred provider relationship between LKPL and Axiometric to further develop Automated Meter Reading (AMR) product suites.\n\n**Obligations:**\n\n* LKPL will provide Axiometric with free office space in its corporate facility in Columbia, Maryland, subject to certain conditions.\n* Axiometric will be responsible for providing its own equipment, furniture, and supplies.\n* Both parties will jointly pursue accessing and commercially penetrating the AMR market.\n\n**Risks:** Axiometric assumes sole risk for its equipment, furniture, and supplies, and must indemnify LKPL and its affiliates against any losses arising from Axiometric's use of the office space. LKPL may terminate Axiometric's license to use office space upon 60 days' notice if it requires the space for its own purposes.",
    "termination": "\"\"NOW, THEREFORE, in consideration of the mutual promises contained herein, the fees to be paid in connection therewith, and other good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties intending to be legally bound, hereby agree as follows:\"\"",
    "confidentiality": "\"\"\"\"NOW, THEREFORE, in consideration of the mutual promises contained\nherein, the parties agree to maintain the confidentiality of all information\nexchanged between them in connection with this Agreement, and to use such\ninformation only for the purposes of this Agreement. The obligations of this\nSection shall survive the termination of this Agreement for a period of two\n(2) years after the date of termination. The parties agree to take all necessary\nsteps to maintain the confidentiality of such information, including but not\nlimited to, marking all confidential information as \"confidential\" and\nlimiting access to such information to employees who have a need to know\nsuch information for the purposes of this Agreement.\"\"\"",
    "liability": "Axiometric will use the space at its sole risk."
  },
  {
    "contract_id": "LiquidmetalTechnologiesInc_20200205_8-K_EX-10.1_11968198_EX-10.1_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Business Development Agreement between Liquidmetal Technologies, Inc. and Eutectix, LLC:\n\n**Purpose:** The agreement aims to facilitate collaboration between Liquidmetal and Eutectix in the development and commercialization of amorphous alloy materials and technologies. Liquidmetal desires to utilize Eutectix's capabilities in amorphous alloy development and manufacturing, while Eutectix seeks to utilize Liquidmetal's processing equipment and methodologies to develop new metallic glass technologies.\n\n**Obligations:** Liquidmetal grants Eutectix a license to use certain equipment owned by Liquidmetal, and Eutectix agrees to perform its obligations under the agreement, including providing product development and manufacturing services to Liquidmetal. The agreement has a term of five years, with automatic extensions of 12 months unless terminated by either party with 180 days' written notice.\n\n**Risks:** The agreement involves risks for both parties, including the potential for intellectual property disputes, equipment damage or malfunction, and delays in product development and manufacturing.",
    "termination": "\"(B) the removal and shipment of the Licensed Equipment, including upon termination or expiration of the Agreement, and (C) protecting or perfecting Liquidmetal’s interest in the Licensed Equipment, including by executing and permitting Liquidmetal to file financing statements and other documents with respect thereto, at Liquidmetal’s expense;\"",
    "confidentiality": "\"\"\"\"confidentiality provisions), and\nany and all rights, remedies and obligations that arose or are incurred prior to expiration or termination, shall survive\nexpiration or termination of this Agreement.\"\"\"",
    "liability": "\"\"\"\"liability company having an address of 323 Main Street, Chatham,\nNew Jersey 07928 (“Eutectix”).\"\" \n\n(Note: There is no explicit liability clause in the provided text. The above is the closest mention of a company with liability, but it does not constitute a liability clause.)"
  },
  {
    "contract_id": "MphaseTechnologiesInc_20030911_10-K_EX-10.15_1560667_EX-10.15_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding Agreement between Lucent Technologies Inc. and mPhase Technologies Inc., including purpose, obligations, and risks:\n\n**Purpose:** The Co-Branding Agreement allows mPhase Technologies Inc. to use the Lucent Technologies name and logo on its products and marketing materials in exchange for permission to do so.\n\n**Obligations:**\n\n* mPhase must use the exact Lucent Co-Branding Logo as specified in Schedule A and abide by guidelines in Schedule B.\n* mPhase must maintain the quality of its products associated with the Lucent Co-Branding Logo.\n* mPhase must notify Lucent of any unauthorized use of the Lucent Co-Branding Logo or other Lucent marks by third parties.\n* Lucent may terminate the Agreement if mPhase's use of the Lucent Co-Branding Logo may adversely affect Lucent's rights to the mark.\n\n**Risks:** Both parties are protected from liability for special, incidental, or consequential damages. However, mPhase may face termination of the Agreement if it fails to meet its obligations, and Lucent may terminate the Agreement if mPhase's use of the Lucent Co-Branding Logo is deemed to be detrimental to Lucent's rights.",
    "termination": "12. Upon termination of this Agreement, mPhase shall immediately cease use\nof the Lucent Co-Branding Logo, provided, however, that mPhase shall\nhave no obligation to remove such Co-Branding Logo from any Goods sold\nprior to the date of such termination.",
    "confidentiality": "\"\"mPhase agrees that it acquires no rights to the Lucent Co-Branding Logo\nnor to the marks LUCENT, LUCENT TECHNOLOGIES or LUCENT INNOVATION RING\nDESIGN, by its use and that any use of the Lucent Co-Branding Logo by\nmPhase inures to the benefit \"\"\"",
    "liability": "\"3. In the event that mPhase's use of the Lucent Co-Branding Logo, in the sole judgment of Lucent, may adversely affect Lucent's rights to the mark shown on Schedule A or the marks and names LUCENT, LUCENT TECHNOLOGIES or LUCENT INNOVATION RING DESIGN, Lucent may upon written notification to mPhase, terminate this Agreement.\""
  },
  {
    "contract_id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Endorsement Licensing and Co-Branding Agreement:\n\n**Purpose:** The agreement aims to establish a partnership between MusclePharm Corporation and Arnold Schwarzenegger (the Endorser) to develop, market, and sell a customized product line (AS Product Line) featuring the Endorser's name and likeness.\n\n**Obligations:**\n\n* MusclePharm is obligated to develop and market the AS Product Line, provide a marketing budget, and obtain the Endorser's approval for all promotional materials.\n* The Endorser is obligated to lend their name, reputation, and appearance to endorse and promote MusclePharm and its products, and to make appearances as agreed upon.\n\n**Risks:** The agreement poses risks for both parties, including the potential for financial losses if the AS Product Line does not meet sales expectations, and reputational risks if the partnership is not successful. Additionally, the agreement's renewal terms and conditions may create uncertainty and potential disputes between the parties.",
    "termination": "\"\"termination of this Agreement and will continue for so long as MusclePharm continues to manufacture, sell or otherwise market the Licensed Products.\"",
    "confidentiality": "The parties acknowledge that during the course of this Agreement the parties will provide to each other certain proprietary and\nconfidential information that is held and maintained confidentially by each party. Each party shall be entitled to share such confidential information\nreceived by such party only with such party’s representatives, legal and accounting advisors who shall agree to be bound by the confidentiality\nobligations set forth in this Section 26. During the term of this Agreement and for three (3) years thereafter, each party shall hold in strict\nconfidence all such information. This obligation shall not apply to any information which: (a) becomes known to the general public through no fault\nof either party; (b) is required to be disclosed in the enforcement of rights hereunder, or (c) is required to be disclosed by any state or federal statue,\nregulation or court order.",
    "liability": "\"(b) By MusclePharm. MusclePharm agrees to protect, indemnify, save, defend, and hold harmless the AS Parties, their related companies, affiliates, and partners, and each of their assigns, agents, representatives, officers, directors, shareholders, and employees from and against any and all expenses, damages, liabilities, claims, suits, actions, judgments, costs and expenses whatsoever (including reasonable attorney’s fees; both those incurred in connection with the defense or prosecution of the indemnifiable claim and those incurred in connection with the enforcement of this provision), caused by, arising out of, or in any way connected with (i) any injury, death, or other harm or claim connected with, or claimed defect in, Products or Licensed Products provided, manufactured, produced, marketed, promoted, sold, and/or distributed by MusclePharm (including any party affiliated with MusclePharm); (ii) any material inaccuracy or misrepresentation by MusclePharm in this Agreement.\""
  },
  {
    "contract_id": "NeoformaInc_19991202_S-1A_EX-10.26_5224521_EX-10.26_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding Agreement between VerticalNet, Inc. and Neoforma.com, Inc., including purpose, obligations, and risks:\n\n**Purpose:** The Co-Branding Agreement aims to establish a partnership between VerticalNet and Neoforma to co-brand career and training centers on their respective websites, promoting medical and healthcare services.\n\n**Obligations:** Both parties agree to:\n\n* Collaborate on the development and maintenance of the Co-Branded Career Center and Co-Branded Training and Education Center.\n* Protect each other's confidential information and intellectual property.\n* Share revenue and expenses related to the co-branded sites.\n* Comply with each other's policies and procedures.\n\n**Risks:** The agreement poses risks for both parties, including:\n\n* Exposure to each other's confidential information and intellectual property.\n* Potential disputes over revenue sharing and expenses.\n* Liability for any damages or losses resulting from the co-branded sites.\n* Dependence on each other's performance and compliance with the agreement.",
    "termination": "11.2 TERMINATION FOR CAUSE. Either Party may terminate this Agreement\nimmediately upon written notice to the other Party in the event any material\nbreach of a material term of this Agreement by such other Party that remains\nuncured 30 days in the case of a breach of a payment obligation, or 45 days for\nall other breaches, after notice of such breach was received by such other\nParty; provided, however that if such breach is not reasonably capable of cure\nwithin the applicable cure period, the breaching Party shall have an additional\n180 days to cure such breach so long as the cure is commenced within the\napplicable cure period and thereafter is diligently prosecuted to completion as\nsoon as possible.\n\n11.3 UPON TERMINATION. Upon termination of this Agreement, (a) each\nParty's liability for any charges, payments or expenses due to the other Party\nthat accrued prior to the date of termination shall not be extinguished by\ntermination, and such amounts (if not otherwise due on an earlier date) shall be\nimmediately due and payable on the termination date; (b) VerticalNet shall be\nresponsible for all charges, payments or expenses incurred by it in connection\nwith the removal of the Neoforma Links, Neoforma Content and Neoforma Product\nListings from the Co-Branded Sites and all other VerticalNet Sites; (c) Neoforma\nshall be responsible for all charges, payments or expenses incurred by it in\nconnection with the removal of the Neoforma Links, Neoforma Content and\nNeoforma Product Listings from the Co-Branded Sites and all other VerticalNet\nSites.",
    "confidentiality": "\"\"\"\"Confidential Treatment Requested\"\"\"",
    "liability": "\"(b) VerticalNet shall be responsible for all charges, payments or expenses incurred by it in connection with the removal of the Neoforma Links, Neoforma Content and Neoforma Product Listings from the Co-Branded Sites and all other VerticalNet Sites;\""
  },
  {
    "contract_id": "NlsPharmaceuticsLtd_20200228_F-1_EX-10.14_12029046_EX-10.14_Development Agreement",
    "summary": "Here is a 100-150 word summary of the License and Development Agreement between NLS-1 Pharma AG (Licensor) and Eurofarma Laboratórios S.A. (Licensee):\n\n**Purpose:** The agreement grants Eurofarma an exclusive license to develop, manufacture, and commercialize Nolazol (Mazindol CR) in Latin America for Attention Deficit Hyperactivity Disorder (ADHD).\n\n**Obligations:**\n\n* Licensor (NLS-1 Pharma AG): grants the license, provides technical assistance, and transfers intellectual property rights.\n* Licensee (Eurofarma Laboratórios S.A.): pays license fees, milestone payments, and royalties, and is responsible for regulatory compliance, pharmacovigilance, and commercialization.\n\n**Risks:** Both parties assume risks related to regulatory approvals, market competition, and intellectual property infringement. The agreement also includes provisions for indemnification, confidentiality, and dispute resolution.",
    "termination": "19.7. Consequences of Expiration or Termination 20",
    "confidentiality": "\"\"\"\"18.1. Confidentiality Obligations 17\n18.2. Exceptions to Obligations 17\n18.3. Survival of Confidentiality Obligations 18\"\"",
    "liability": "\"\"\"\"20.4. No Waiver 21\"\" \n\n(Note: There is no explicit liability clause in the provided text. The above is the closest related clause, which is about waiver.)"
  },
  {
    "contract_id": "PaperexchangeComInc_20000322_S-1A_EX-10.4_5202103_EX-10.4_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding Agreement between VerticalNet, Inc. and PaperExchange.com, LLC:\n\n**Purpose:** The Co-Branding Agreement aims to establish a partnership between VerticalNet and PaperExchange to co-brand their websites, creating a joint online presence for career and equipment listings in the pulp and paper industry.\n\n**Obligations:** Both parties agree to:\n\n* Collaborate on the development and maintenance of the Co-Branded Sites\n* Share revenue generated from the Co-Branded Sites\n* Protect each other's confidential information\n* Comply with the terms and conditions of the agreement\n\n**Risks:** The agreement outlines potential risks, including:\n\n* Termination of the agreement, which may result in loss of revenue and damage to reputation\n* Breach of confidentiality, which may lead to financial losses and damage to business relationships\n* Changes in market conditions, which may impact the success of the Co-Branded Sites.",
    "termination": "\"\"\"termination of this Agreement, VerticalNet shall not, directly or indirectly, by\nitself, through its Affiliates or through any type of joint venture or similar\naffiliation with a third party, without prior written approval from\nPaperExchange, buy, sell or trade (a) paper pulp products through exchanges,\nauctions, or reverse auctions or any other e-commerce medium, (b) paper (other\nthan finished paper-based products, including, but not limited to, books, stamps\nand labels) and copy paper (i) through exchanges, auctions or reverse auctions\nor (ii) in quantities greater than one ton through any e-commerce medium, (c)\nraw materials used to make paper packaging, including, but not limited to,\nlinerboard, medium, other containerboard grades and corrugated sheet through\nexchanges, auctions, reverse auctions or any other e-commerce medium, or (d)\npaper rolls and reels weighing more than 50 pounds used by printers through\nexchanges, auctions, reverse auctions or any other e-commerce medium; provided,\nhowever, that this Section 5.8.1 [Non-Competition] shall not apply to advertisements, Storefronts\nor similar features on VerticalNet's Sites.\"\"\"",
    "confidentiality": "\"Confidential Information shall mean all proprietary and confidential\ninformation of a party, including, without limitation, trade secrets, technical\ninformation, business information, sales information, customer and potential\ncustomer lists and identities, product sales plans, sublicense agreements,\ninventions, developments, discoveries, software, know-how, methods, techniques,\nformulae, data, processes and other trade secrets and proprietary ideas, whether\nor not protectable under patent, trademark, copyright or other areas of law,\nthat the other party has access to or receives, but does not include information\nthat (a) is or becomes publicly available through no fault of receiving party;\n(b) was already known to the receiving party at the time it was disclosed to the\nreceiving party, as evidenced by written records of the receiving party; (c) is\nindependently developed by employees of the receiving party who had no knowledge\nof or\n* Confidential Treatment Requested: material has been omitted and filed\nseparately with the Commission.\naccess to such information, as evidenced by written records of the receiving\nparty; or (d) is received from a third party who is under no obligation of\nconfidentiality to the disclosing party.\"",
    "liability": "\"\"\"\"In consideration of the mutual covenants herein, and intending to be legally bound hereby, the parties agree as follows:\"\"\""
  },
  {
    "contract_id": "PcquoteComInc_19990721_S-1A_EX-10.11_6377149_EX-10.11_Co-Branding Agreement1",
    "summary": "Here is a 100-150 word summary of the Co-Branding Agreement between PC QUOTE, INC. (PCQ) and AB Wately, Inc. (ABW):\n\n**Purpose:** The agreement enables ABW to co-brand PCQ's software application, PC QUOTE 6.0-TM, on its World Wide Web site, providing a value-added service to its subscribers.\n\n**Obligations:**\n\n* PCQ agrees to provide a continuous HYPERFEED to ABW servers and control access to the market data.\n* ABW agrees to sign up new subscribers, execute service and exchange agreements, and include PCQ's branding and disclaimer on the co-branded pages.\n* Both parties retain title and copyrights to the software and HYPERFEED.\n\n**Risks:** ABW may face risks related to unauthorized access to the co-branded service, reproduction, or redistribution of the service, and potential liability for errors or omissions in the market data information. PCQ may face risks related to unauthorized access to the HYPERFEED and potential liability for errors or omissions in the market data information.",
    "termination": "C. Notwithstanding the provisions of (A), and (B) above, should a party\nto this Agreement be in material breach of the Agreement, the other party may\nterminate the Agreement thirty (30) days after notice of said material breach\nis received, and only if such material breach is not cured within thirty (30)\ndays of receipt of notice.",
    "confidentiality": "\"\"\"\"CONFIDENTIAL TREATMENT\nPortions indicated by a\n[***] have been omitted\nand filed separately\nwith the Commission\"\"",
    "liability": "\"liability for truth, accuracy, or completeness of the market data information nor is PC Quote liable for errors, mistakes or omissions in the data or for any delays or interruptions in the end user's receipt of the data. PC Quote does not warrant that the data provided may be relied upon for trading purposes.\""
  },
  {
    "contract_id": "PcquoteComInc_19990721_S-1A_EX-10.11_6377149_EX-10.11_Co-Branding Agreement2",
    "summary": "Here is a 100-150 word summary of the contract:\n\n**Purpose:** This amendment to the Co-Branding Agreement between PC Quote, Inc. (PCQ) and A.B. Watley, Inc. (ABW) modifies the term of their partnership. The amendment aims to clarify the duration of their co-branding agreement.\n\n**Obligations:** Both parties, PCQ and ABW, are obligated to adhere to the terms of the Co-Branding Agreement, as amended. This includes any obligations and responsibilities outlined in the original agreement, which are now subject to the modified term.\n\n**Risks:** The amendment does not explicitly outline any new risks or liabilities for either party. However, failure to comply with the terms of the agreement may result in legal consequences, including potential damages or termination of the agreement. The parties must carefully review and understand their obligations to avoid any potential risks or disputes.",
    "termination": "\"\"\"\"This amendment to Section 2 (titled \"Term\"), Part B of the Co-Branding Agreement is made effective December 9, 1996 by and between PC Quote, Inc. (hereinafter referred to as \"PCQ\") and A.B. Watley, Inc. (hereinafter referred to as \"ABW\"), who are also the parties contracted in the aforementioned Co-Branding Agreement.\"\"\"",
    "confidentiality": "\"\"\"\"[LOGO]\nAMENDMENT TO SECTION 2, PART B OF THE CO-BRANDING AGREEMENT\n\nThis amendment to Section 2 (titled \"Term\"), Part B of the Co-Branding\nAgreement is made effective December 9, 1996 by and between PC Quote, Inc.\n(hereinafter referred to as \"PCQ\") and A.B. Watley, Inc. (hereinafter\nreferred to as \"ABW\"), who are also the parties contracted in the\naforementioned Co-Branding Agreement. This Amendment shall apply to said PCQ\nand ABW and all of their subsidiaries and related companies.\n[***]\"\" \n\n(Note: There is no confidentiality clause in the provided text.)",
    "liability": "\"\"\"\"This Amendment shall apply to said PCQ and ABW and all of their subsidiaries and related companies.\"\"\""
  },
  {
    "contract_id": "PcquoteComInc_19990721_S-1A_EX-10.11_6377149_EX-10.11_Co-Branding Agreement3",
    "summary": "Here is a 100-150 word summary of the Second Amendment to the Co-Branding Agreement:\n\n**Purpose:** The Second Amendment to the Co-Branding Agreement is made to modify the provisions of the agreement regarding certain terms and conditions. The amendment aims to update and clarify the agreement between PC Quote, Inc. (PCQ) and A.B. Watley, Inc. (ABW).\n\n**Obligations:** PCQ and ABW agree to the terms and conditions outlined in the amendment, which includes the deletion of certain provisions and the insertion of new language. The parties also acknowledge that the amendment prevails over any conflicting provisions in the original agreement.\n\n**Risks:** The amendment may introduce new risks or liabilities for both parties, particularly if the modified provisions are not clearly understood or implemented. Failure to comply with the amended terms and conditions may result in disputes, penalties, or other adverse consequences.",
    "termination": "\"\"NOW, THEREFORE, in consideration of the foregoing, of the mutual\npromises for the parties contained herein and of other good valuable\nconsideration, the receipt and sufficiency of which are hereby acknowledged,\nthe parties hereto, intending legally to be bound, hereby covenant and agree\nas follows:\"\"",
    "confidentiality": "\"\"\"\"NOW, THEREFORE, in consideration of the foregoing, of the mutual\npromises for the parties contained herein and of other good valuable\nconsideration, the receipt and sufficiency of which are hereby acknowledged,\nthe parties hereto, intending legally to be bound, hereby covenant and agree\nas follows:\"\"\"",
    "liability": "\"\"3. To the extent, if any, that provision of this Agreement conflicts with or differs from any provision of the Agreement, such provision of this Second Amendment shall prevail and govern for all purposes and in all respects.\"\""
  },
  {
    "contract_id": "PelicanDeliversInc_20200211_S-1_EX-10.3_11975895_EX-10.3_Development Agreement1",
    "summary": "Here is a 100-150 word summary of the contract, including purpose, obligations, and risks:\n\n**Purpose:** The contract between Pelican Delivers, Inc. and Seattle Software Developers outlines the scope of work for developing additional features for the Pelican Delivers software, including POS integration, Google Maps API, payment processing features, ID verification, reporting, driver app improvement, and a front-facing web application for customers.\n\n**Obligations:** Seattle Software Developers is obligated to deliver the project within six months, with milestones and payment schedules outlined in the contract. Pelican Delivers, Inc. is obligated to pay a total of $279,000 in four installments, with a 20% deposit at the start of the project and subsequent payments upon completion of each milestone.\n\n**Risks:** The contract outlines potential risks, including unforeseen circumstances or requirements that may impact the project timeline and budget. Additionally, the contract requires Pelican Delivers, Inc. to verify the age of users accessing the website, which may pose a risk of non-compliance with regulations.",
    "termination": "\"\"\"\"STATEMENT OF WORK - APPENDIX A\nThis Statement of Work is issued to and made part of that Software Development Agreement executed by and between Developer and Client on the\nEffective Date (the Agreement). Any word or phrase not otherwise defined in this Appendix will have the meaning ascribed in the Agreement.\"\"\"",
    "confidentiality": "\"\"\"\"STATEMENT OF WORK - APPENDIX A\n\nThis Statement of Work is issued to and made part of that Software Development Agreement executed by and between Developer and Client on the\nEffective Date (the Agreement). Any word or phrase not otherwise defined in this Appendix will have the meaning ascribed in the Agreement.\"\"\"",
    "liability": "\"\"Any word or phrase not otherwise defined in this Appendix will have the meaning ascribed in the Agreement.\"\""
  },
  {
    "contract_id": "PelicanDeliversInc_20200211_S-1_EX-10.3_11975895_EX-10.3_Development Agreement2",
    "summary": "Here is a 100-150 word summary of the Software Development Agreement:\n\n**Purpose:** The Software Development Agreement is made between Dot Com LLC (Developer) and Pelican Delivers Inc. (Client) for the performance of software design services and software development for the \"Pelican Delivers Application Phase 1\" project.\n\n**Obligations:**\n\n* Developer will design, develop, and deliver the software application, documentation, and user manuals as specified in the project specifications.\n* Client will perform acceptance tests and notify Developer of any defects or changes required within 10 days of the acceptance test date.\n* Developer will correct any defects or changes within 20 days of receiving a change request from Client.\n\n**Risks:** Failure to meet project deadlines, defects in the software application, and changes to the project specifications may result in delays, additional costs, or termination of the agreement.",
    "termination": "\"\"\"\"termination of\nDeveloper's services and work product as mutually agreed upon between the Parties (the Project).\"\"",
    "confidentiality": "6.4.1 Confidential Information. Each Party acknowledges and agrees that it will receive confidential information and trade secrets from the other\nParty in otherwise carrying out the actions contemplated by this Agreement (collective, Confidential Information). Confidential Information does\nnot include information at: (a) is available to the public or that becomes available to the public through no act or failure to act by the receiving Party\n(Receiving Party); (b) is known to the Receiving Party prior to the date of disclosure by the disclosing Party (Disclosing Party), unless the\nReceiving Party agreed to keep such information in confidence at the time of receipt of the information; (c) is properly obtained hereafter from a\nsource that is not under an obligation of confidentiality with respect to such information; or (d) is developed independently by the Receiving Party\nwithout reference to or use of the Disclosing Party's Confidential Information.\n\n6.4.2 Non-Disclosure. Neither Party shall use or disclose Confidential Information of the other Party to any third party, without the written consent\nof the Disclosing Party of such Confidential Information. Receiving Party agrees to undertake reasonable measures to maintain and preserve the\nConfidential Information of the Disclosing Party in confidentiality.",
    "liability": "\"\"\"\"liability company (Developer ), and (Client) Pelican Delivers Inc. for the performance of\nsoftware design services and software development as detailed herein (Developer and Client are individually referred to herein as a Party, and\ncollectively as the Parties).\"\"\""
  },
  {
    "contract_id": "PhasebioPharmaceuticalsInc_20200330_10-K_EX-10.21_12086810_EX-10.21_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Development Agreement between PhaseBio Pharmaceuticals Inc. (PB) and SFJ Pharmaceuticals X, Ltd. (SFJ):\n\n**Purpose:** The agreement aims to facilitate the development and approval of a pharmaceutical product, referred to as the \"Product,\" as a treatment for patients affected by the Ticagrelor Compound. PB will conduct clinical trials in the United States and European Clinical Trial Countries, while SFJ will provide operational support for clinical trials in European Clinical Trial Countries and Designated Asian Countries, as well as global financing for the Product's continued development.\n\n**Obligations:** PB is responsible for conducting clinical trials, while SFJ will provide operational support and financing. Both parties must comply with applicable laws, regulations, and guidelines, including anti-corruption laws and Good Clinical Practice (GCP) guidelines.\n\n**Risks:** The agreement involves significant risks, including the potential failure of clinical trials, regulatory approval issues, and financial risks associated with the development and commercialization of the Product.",
    "termination": "\"\"\"termination of the AZ License, (a) in the case of the\nconduct of human clinical trials with respect to a Competing Product, the period beginning on the Effective Date and ending on\nNovember 21, 2022, and (b) in the case of the sale or offer for sale of a Competing Product, the period beginning on the Effective\nDate and ending on November 21, 2024.\"\"\"",
    "confidentiality": "\"Confidential Information” of a Party means all information and materials provided and/or disclosed (including in written form, electronic form or otherwise) by, or on behalf of, such Party or its Affiliates, agents or representatives to the other Party, its Affiliates, agents or representatives in connection with this Agreement, including, technical, scientific, regulatory and other information, results, knowledge, techniques, data, analyses, inventions, invention disclosures, plans, processes, methods, know-how, ideas, concepts, test data (including pharmacological, toxicological and clinical test data), analytical and quality control data, formulae, specifications, marketing, pricing, distribution, cost, sales, and manufacturing data and descriptions.",
    "liability": "(i) Indebtedness (as defined in Section 7.7.3) of that Person, and (ii) any direct or indirect liability, contingent or not, of that Person for (a) warranty obligations, (b) potential claims for damages, (c) assessments, and (d) any other condition, situation or set of circumstances involving various degrees of uncertainty that may result in a loss or liability."
  },
  {
    "contract_id": "RaeSystemsInc_20001114_10-Q_EX-10.57_2631790_EX-10.57_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding Agreement between Nettaxi Online Communities, Inc. and Solutions Media, Inc. (SpinRecords.com):\n\n**Purpose:** The Co-Branding Agreement aims to enable Nettaxi and SpinRecords.com to co-brand their services, promoting mutual benefits and increasing user engagement.\n\n**Obligations:**\n\n* Nettaxi shall provide electronic copies of its brand features to SpinRecords.com upon request.\n* SpinRecords.com shall brand its pages with Nettaxi's brand features in the manner set forth in the Statement of Work.\n* Both parties shall display appropriate intellectual property legends on their respective pages.\n* Nettaxi shall not be obligated to co-brand pages containing content branded with a third party, unless commercially reasonable.\n\n**Risks:** Failure to comply with the agreement's terms may result in reputational damage, loss of business opportunities, and potential intellectual property disputes.",
    "termination": "8.2 Convenience. NETTAXI may terminate this Agreement at any time for\n-----------\nits convenience, for no reason or for any reason, upon sixty (60) days prior\nwritten notice to SpinRecords.com. In the event of such termination,\nSpinrecords.com shall be entitled to receive and retain all payments made or\npayable by NETTAXI prior to the date of termination. SpinRecords.com may\nterminate this Agreement for no reason or for any reason upon sixty (60) days\nprior written notice to NETTAXI.\n\n8.3 Termination for Cause. This Agreement may be terminated by a party\n----------------------\nfor cause immediately upon the occurrence of and in accordance with the\nfollowing:\n(a) Insolvency Event. Either may terminate this Agreement by\ndelivering written notice to the other party upon the occurrence of any of the\nfollowing events: (i) a receiver is appointed for either party or its property;\n(ii) either makes a general assignment for the benefit of its creditors; (iii)\neither party commences, or has commenced against it, proceedings under any\nbankruptcy, insolvency or debtor's relief law, which proceedings are not\ndismissed within sixty (60) days; or (iv) either party is liquidated or\nSource: RAE SYSTEMS INC, 10-Q, 11/14/2000\n\ndissolved.\n(b) Change of Control. In the event more that there is a change in\nownership representing fifty percent (50%) or more of the equity ownership of\neither party, the other party may, at its option, terminate this Agreement upon\nwritten notice.\n(c) Default. Either party may terminate",
    "confidentiality": "6.1 Agreement as Confidential Information. The parties shall treat the\nterms and conditions and the existence of this Agreement as Confidential\nInformation. Each party shall obtain the other's consent prior to any\npublication, presentation, public announcement or press release concerning the\nexistence or terms and conditions of this Agreement.\n\n6.2 Confidential Information. \"Confidential Information\" means all\ninformation identified in written or oral format by the Disclosing Party as\nconfidential, trade secret or proprietary information, and, if disclosed orally,\nsummarized in written format within thirty (30) days of disclosure.",
    "liability": "7.1 Indemnification by Spinrecords.com. SpinRecords.com shall defend, indemnify and hold NETTAXI harmless from any and all damages, liabilities, costs and expenses (including, but not limited to reasonable attorneys' fees) incurred by NETTAXI as a result of (i) any breach of this Agreement; (ii) any claim that the SpinRecords.com Brand Features or any part thereof, infringes or misappropriates any Intellectual Property Right of a third party; (iii) any claim arising out of NETTAXI's display of the SpinRecords.com Brand Features; or (iv) the operation of the SpinRecords.com Pages. NETTAXI shall provide SpinRecords.com with written notice of the claim and permit SpinRecords.com to control the defense, settlement, adjustment or compromise of any such claim. NETTAXI may employ counsel at its own expense to assist it with respect to any such claim; provided, however, that if such counsel is necessary because of a conflict of interest of either SpinRecords.com or its counsel or because SpinRecords.com does not assume control, SpinRecords.com will bear the expense of such counsel.\n\n7.2 Indemnification by NETTAXI. NETTAXI shall defend, indemnify and hold SpinRecords.com harmless from any and all damages, liabilities, costs and expenses (including, but not limited to reasonable attorneys' fees) incurred by SpinRecords.com as a result of (1) any breach of this Agreement; (ii) any claim that the NETTAXI Brand Features or any part thereof, infringes or misappropriates any Intellectual Property Right of a third party; or (iii) any claim arising out of Spinrecords.com's display of the NETTAXI Brand Features SpinRecords.com shall provide NETTAXI with written notice of the claim and permit NETTAXI to control the defens"
  },
  {
    "contract_id": "RandWorldwideInc_20010402_8-KA_EX-10.2_2102464_EX-10.2_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding Agreement:\n\n**Purpose:** The Co-Branding Agreement is made between Dassault Systemes and PlanetCAD to co-brand PlanetCAD's 3Dshare.com Web site with Dassault Systemes' services, creating a new service called the Co-Branded Service.\n\n**Obligations:** Dassault Systemes is responsible for billing and collection matters associated with the Co-Branded Service, while PlanetCAD is responsible for providing its expertise in Internet-based services to customers. Both parties agree to maintain confidentiality and non-disclosure of certain information.\n\n**Risks:** The agreement poses risks for both parties, including the potential for intellectual property disputes, breaches of confidentiality, and failure to meet the terms of the agreement. Additionally, the agreement may expose PlanetCAD to liability for Dassault Systemes' actions, and vice versa. The parties must carefully manage these risks to ensure the success of the Co-Branded Service.",
    "termination": "\"The license granted pursuant to this Section 3.3 [Limited Hosting License] shall be deemed to be automatically revoked upon termination of this Agreement.\"",
    "confidentiality": "\"\"\"\"confidential treatment under Rule 24b-2 of the General Rules and Regulations\nunder the Securities Exchange Act. Omitted information, marked \"[***]\" in this\nexhibit, has been filed with the Securities and Exchange Commission together\nwith such request for confidential treatment.\"\"\"",
    "liability": "9.1 Dassault Systemes Indemnification. Dassault Systemes shall\nindemnify and hold harmless PlanetCAD, and its officers, directors, employees,\nand shareholders from and against any claims, demands, suits, causes of action,\nlosses, damages, judgments, costs and expenses (including reasonable attorneys'\nfees) arising out of or related to any breach of Dassault Systemes'\nrepresentations, warranties and covenants set forth in this Agreement.\n\n9.2 PlanetCAD Indemnification. PlanetCAD shall indemnify and\nhold harmless Dassault Systemes, its affiliates, and their respective officers,\ndirectors, employees, and shareholders from and against any claims, demands,\nsuits, causes of action, losses, damages, judgments, costs and expenses\n(including reasonable attorneys' fees) arising out of or related to any breach\nof PlanetCAD's representations, warranties and covenants set forth in this\nAgreement.\n\n9.3 Intellectual Property Infringement.Each Party agrees to\nhold the other Party, its subsidiaries and distributors and assignees harmless\nfrom and against any claim of any nature, including, but not limited to,\nadministrative, civil or criminal procedures, which is or may be made or raised\nagainst this Party, its subsidiaries and distributors and assignees by any third\nparty that the use or distribution of the Software or any other intellectual\nproperty that is the subject of this Agreement and owned or licensed by this\nParty, infringes or violates any third party's patent, copyright, trade secret\nor other intellectual property right in any country. Indemnification hereunder\nshall cover all damages, regardless of their nature, settlements, expenses and\ncosts, including costs of investigation, court costs and attorneys' fees. The\npayment of any indemnification shall be contingent on:"
  },
  {
    "contract_id": "ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Recipe Development Agreement:\n\n**Purpose:** The Recipe Development Agreement is made between Reed's, Inc. and Full Sail Brewing Company to develop formulas for ginger-based flavored alcohol beverage products.\n\n**Obligations:**\n\n* Reed's grants Full Sail Brewing Company the exclusive right to manufacture, package, promote, sell, and distribute the products, subject to a separate Manufacturing and Distribution Agreement.\n* Full Sail Brewing Company is responsible for all costs related to the development of recipes and deliverables, except for costs and expenses related to Reed's personnel and contractors.\n* Both parties agree to participate in the Development Committee to oversee the development process.\n\n**Risks:** The agreement outlines the risks associated with the development of new products, including the potential for intellectual property disputes and the need for compliance with applicable laws and regulations.",
    "termination": "\"\"termination or expiration of this Agreement.\"\"\"",
    "confidentiality": "\"(iv) trade secrets and confidential information;\"",
    "liability": "10. Limitation of Liability. EXCEPT WITH RESPECT TO THE INDEMNIFICATION OBLIGATIONS SET FORTH IN SECTION 9 WITH\nREGARD TO CLAIMS BY THIRD PARTIES, IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR CONSEQUENTIAL, INDIRECT,\nINCIDENTAL, SPECIAL, EXEMPLARY, PUNITIVE OR ENHANCED DAMAGES, LOST PROFITS OR REVENUES OR DIMINUTION IN VALUE\nARISING OUT OF, RELATING TO, OR IN CONNECTION WITH ANY BREACH OF THIS AGREEMENT OR CLAIM HEREUNDER, REGARDLESS\nOF (A) WHETHER SUCH DAMAGES WERE FORESEEABLE, (B) WHETHER OR NOT IT WAS ADVISED OF THE POSSIBLITY OF SUCH\nDAMAGES, AND (C) THE LEGAL OR EQUITABLE THEORY (CONTRACT, TORT OR OTHERWISE) UPON WHICH THE CLAIM IS BASED."
  },
  {
    "contract_id": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Collaborative Research, Development, and Commercialization Agreement between Revolution Medicines, Inc. (RevMed) and Aventis, Inc. (Sanofi):\n\n**Purpose:** The agreement aims to establish a collaboration between RevMed and Sanofi for the research, development, and potential commercialization of drug candidates and biologic compounds that inhibit the activity of the cancer target SHP2.\n\n**Obligations:** RevMed and Sanofi agree to share resources, expertise, and costs to advance the development of SHP2 inhibitors. RevMed grants Sanofi licenses to develop and commercialize SHP2 inhibitors, while Sanofi agrees to make milestone payments and royalties to RevMed.\n\n**Risks:** The agreement involves significant risks, including the failure of SHP2 inhibitors to demonstrate efficacy and safety in clinical trials, competition from other pharmaceutical companies, and potential regulatory hurdles. Additionally, the agreement includes provisions for termination and dispute resolution, which may lead to costly and time-consuming litigation.",
    "termination": "\"Termination Product Section 12.3(c)(ii)(A)\nParent Section 1.12\nParty or Parties Preamble\nPharmacovigilance Agreement Section 6.5\n17\nSource: REVOLUTION MEDICINES, INC., S-1, 1/17/2020\n\nDefined Term Section\nProduct Infringement Section 10.4(a)\nProduct Marks Section 10.5(a)\nProfit/Loss Share Agreement Section 9.4\nQuality Agreement Section 7.3\nReceiving Party Section 11.1(a)\nRemainder Section 10.4(f)\nRemedial Action Section 6.7\nResearch Budget Section 4.2(a)\nResearch Plan Section 4.1\n[***] Section 4.2(b)\nRevMed Preamble\nRevMed Commercialization Costs Section 8.2\nRevMed Indemnitee Section 14.2\nRevMed Program Invention Section 12.3(c)(ii)\nRevMed Study Section 5.6(b)\nRoyalty Floor Section 9.3(c)(iii)\nRoyalty Term Section 9.3(b)\nSanofi Preamble\nSanofi Indemnitee Section 14.1\nSanofi Program Invention Section 12.3(c)(ii)\nSanofi Prosecuted Patents Section 10.2(a)\n[***] Section 12.3(c)(ii)\n[***] Section 12.3(c)(ii)\n[***] Section 12.3(c)(ii)\nSHP1-SHP2 Dual Inhibitor License Rights Section 3.5(a)\nSHP1-SHP2 Dual Inhibitor Licensing Decision Section 3.5(a)\nSHP1-SHP2 Dual Inhibitor Licensing Negotiation Period Section 3.5(a)\nStock Sale Section 1.12\nSupply Agreement Section 7.3\nTerm Section 12.1\nThird Party Right Section 10.7(a)\nTermination Product Section 12.3(c)(ii)(D)\nThird Party Right Notification Section 10.7(a)\nVAT Section 9.7(b)\n1.132 Interpretation. In this Agreement, unless otherwise specified:\n(a) The words “include”, “includes” and “including” shall be deemed to be followed by the phrase “without limitation”;\n(b) the words “will” and “shall” have the same meaning;\n18\nSource: REVOLUTION MEDICINES, INC., S-1, 1/17/2020\n\n(c) the word “or” shall be interpreted to mean “and/or” unless the context requires otherwise;\n(d) words denoting the singular shall include the plural and vice versa and w\"\"\"\n\n\"Termination Product Section 12.3(c)(ii)(D)\"",
    "confidentiality": "\"Confidential Information” of a Party means all proprietary Know-How, unpublished patent applications and other non-public information\nand data of a financial, commercial, business, operational or technical nature of such Party that is disclosed by or on behalf of such Party, its Affiliates or\nits or their Sublicensees, or otherwise made available to the other Party, its Affiliates or its or their Sublicensees, prior to, on or after the Effective Date,\nwhether made available orally, in writing or in electronic form in connection with this Agreement or any Ancillary Agreement, including the terms of this\nAgreement and any Ancillary Agreements, information comprising or relating to concepts, discoveries, inventions, data, designs or formulae in\nconnection with this Agreement or any Ancillary Agreement. All (a) RevMed Licensed Know-How to the extent relating to SHP2 Inhibitors or Products,\n(b) Joint Program Know-How, and (c) the terms of this Agreement and any Ancillary Agreements, shall be deemed to be the Confidential Information of\nboth Parties (and both Parties shall be deemed to be the Receiving Party and the Disclosing Party with respect thereto). All RevMed Licensed Know-How\nto the extent relating to RevMed’s products and product candidates (other than SHP2 Inhibitors or Products) shall not be deemed Confidential\nInformation of both Parties.",
    "liability": "\"\"\"\"liability, loss, damage, injury, costs or expenses (including reasonable attorneys’ fees and expenses of litigation)\nof any kind.\"\"\""
  },
  {
    "contract_id": "RitterPharmaceuticalsInc_20200313_S-4A_EX-10.54_12055220_EX-10.54_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Distribution and Development Agreement between Sekisui Diagnostics, LLC and Qualigen, Inc., including purpose, obligations, and risks:\n\n**Purpose:** The Distribution and Development Agreement aims to establish Sekisui as the exclusive distributor of Qualigen's clinical rapid diagnostic test devices and controls in the specified Territory, while also funding the development of future products.\n\n**Obligations:** Sekisui is obligated to distribute Qualigen's products in the Territory, while Qualigen is obligated to provide Sekisui with the necessary products and support. Both parties are also required to maintain confidentiality and intellectual property rights.\n\n**Risks:** The agreement poses risks for both parties, including the potential for adverse events, product liability, and intellectual property disputes. Additionally, Sekisui's exclusivity period ends on December 31, 2018, after which Qualigen may appoint other distributors.",
    "termination": "\"\"\"termination of the Term (other than in connection with a Sale Transaction in which Sekisui acquires Qualigen), Sekisui shall cooperate in permitting Qualigen to offer to rehire any Sekisui sales representatives who are primarily responsible for selling the Products.\"\"\"",
    "confidentiality": "\"\"\"\"confidential information; and (d) rights in any trade names, trademarks, service marks, domain names, logos, trade dress and brand features.\"\"\"",
    "liability": "\"\"NOW, THEREFORE, in consideration of the mutual covenants hereinafter contained, the parties hereto agree as follows:\"\""
  },
  {
    "contract_id": "SouthernStarEnergyInc_20051202_SB-2A_EX-9_801890_EX-9_Affiliate Agreement",
    "summary": "Here is a 100-150 word summary of the Affiliate Program/Premium Affiliate Management General Terms and Conditions:\n\n**Purpose:** The Affiliate Program is designed to allow web site owners (Affiliates) to participate in a revenue-sharing program by publishing electronic advertisements for selected software products offered by element 5 Software Publishers. In exchange for publishing the advertisements, Affiliates receive result-dependent Advertising Cost Compensation (Commission) based on actual sales generated by end users referred via the electronic advertisement.\n\n**Obligations:**\n\n* Affiliates must register and be activated by a Software Publisher to participate in the program.\n* Affiliates must keep their user ID and password confidential and secure.\n* Software Publishers must activate Affiliates for specific software products before they can be offered on the Affiliate's web site.\n\n**Risks:** The program involves risks for both parties, including the potential for unauthorized access to the Affiliate Control Panel or Software Publisher's Control Panel, which could compromise sensitive sales data and end user information.",
    "termination": "\"\"\"\"termination of existing partnerships.\"\"\"",
    "confidentiality": "The Affiliate shall take due care to ensure that no unauthorized parties learn the password.",
    "liability": "§ 6 Limitation of liability\n(1) The parties exclude mutual liability for slightly negligent violation\nof obligations in connection with this agreement, with the exception of §\n16 and § 5 (3) of this agreement. This includes in particular the liability\nexclusion for lost profit, the loss of data or interruption to or errors in\nthe operation of the Web site of the Affiliate. The above liability\nexclusion also applies to the personal liability of employees,\nrepresentatives and persons employed to perform the obligations of the\nparties to the agreement. The limitation of liability does not apply to\nclaims arising through initial incapacity or in case of justifiable\nimpossibility.\n(2) Any possible product liability claims are unaffected by the above\nlimitations. Insofar as element 5 or the Software Publisher violates an\nessential obligation under the agreement, the obligation to pay restitution\nis limited to the damages that typically arise.\n(3) element 5 makes no guarantees in regard to the Software Publisher's\nsoftware products offered via its Web site. Moreover, element 5 does not\nguarantee the Affiliate that the operation of its Web sites will be\nmaintained without interruptions and without errors. Liability is expressly\nexcluded for the consequences of such interruptions or errors."
  },
  {
    "contract_id": "StampscomInc_20001114_10-Q_EX-10.47_2631630_EX-10.47_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Manifest System Services and Co-Branding Agreement between iShip.com, Inc. (the Company) and Mail Boxes Etc. USA, Inc. (MBE):\n\n**Purpose:** The agreement aims to provide MBE with access to the Company's Internet-based shipping system for use in manifesting and shipping customer packages, while also engaging in co-branding activities on the Internet.\n\n**Obligations:**\n\n* The Company will provide MBE with access to its Internet-based shipping system and technical support.\n* MBE will use the Company's system in accordance with the terms and conditions of the agreement.\n* The Company will issue a warrant to MBE to purchase up to 1,333,333 shares of Series B Preferred Stock.\n\n**Risks:** The agreement involves the sharing of confidential information and intellectual property rights between the parties, which may pose risks to each party's business and competitive position. Additionally, the agreement requires MBE to use the Company's system in accordance with the terms and conditions, which may limit MBE's flexibility and autonomy.",
    "termination": "\"\"Termination]) or as otherwise agreed\nin writing, MBE and MBE Centers may not, directly, or through any person or\nentity, in any form or manner, copy, distribute, reproduce, incorporate, use or\nallow access to the Service or the Specifications, or modify, prepare derivative\nworks of, decompile, reverse engineer, disassemble or otherwise attempt to\nderive source code or object code from the Service or the Specifications.\"\"",
    "confidentiality": "\"Confidential Information\" shall mean the Service Documentation, the\nSpecifications and any information disclosed by one party to the other pursuant\nto this Agreement that is in written, graphic, machine readable or other\ntangible form and is marked \"Confidential,\" \"Proprietary\" or in some other\nmanner to indicate its confidential nature, including but not limited to\ninformation related to the respective parties' business, products, proposed new\nproducts, customers or related information. Confidential Information may also\ninclude oral information disclosed by one party to the other pursuant to this\nAgreement, provided that such information is designated as confidential at the\ntime of disclosure and is reduced to writing by the disclosing party within a\nreasonable time (not to exceed thirty (30) days) after its oral disclosure, and\nsuch writing is marked in a manner to indicate its confidential nature and\ndelivered to the receiving party.",
    "liability": "\"Company acknowledges and agrees that each participating MBE Center is an independently owned and operated franchise and that MBE is not responsible for any debts or acts or omissions of its franchisees.\""
  },
  {
    "contract_id": "SteelVaultCorp_20081224_10-K_EX-10.16_3074935_EX-10.16_Affiliate Agreement",
    "summary": "Here is a 100-150 word summary of the Marketing Affiliate Agreement:\n\n**Purpose:** The Marketing Affiliate Agreement is a contract between Equidata, Inc. and National Credit Report.com, LLC, where the latter is permitted to market Equidata's personal credit, fraud detection, and credit monitoring services.\n\n**Obligations:** Marketing Affiliate is responsible for collecting payments from consumers and bearing the risk of non-payment. Equidata will provide the services and bill Marketing Affiliate on a bi-monthly basis. Marketing Affiliate must pay all charges incurred through services rendered, including any late charges, returned check fees, and attorney's fees in case of non-payment. Marketing Affiliate also agrees to reimburse Equidata for costs of collecting past due amounts.\n\n**Risks:** Marketing Affiliate assumes the risk of non-payment by consumers and must bear the costs of collection, including attorney's fees. Additionally, Marketing Affiliate may be liable for any unpaid balance past due on any invoice, and may be subject to a late charge of 1.5% per month on the unpaid amount.",
    "termination": "\"Upon termination for any reason, Equidata reserves the right to deactivate Marketing Affiliate’s access to the services including the Equidata Web Site. Termination does not release Marketing Affiliate from paying all amounts owed to Equidata.\"",
    "confidentiality": "Confidential Information, includes, but is not limited to, Customer names and lists. The Receiving Party may not disclose or use the Disclosing Party’s Confidential and Proprietary Information for any reason other than in the performance of this Agreement. It is agreed any information received or collected by Marketing Affiliate about its Customers or potential Customers, including information used to enroll Customers is Proprietary as defined by this section and will not be used by Equidata in any manner other than as outlined herein.",
    "liability": "IN NO EVENT WILL EQUIDATA BE LIABLE FOR ANY INDIRECT, EXEMPLARY, PUNITIVE, SPECIAL, OR CONSEQUENTIAL DAMAGES INCLUDING WITHOUT LIMITATION LOST PROFITS OR OTHER ECONOMIC LOSS, LOST REIMBURSEMENTS, AND LOST DATA, OR FOR ANY CLAIM BY ANY THIRD PARTY. EVEN IF EQUIDATA, MARKETING AFFILIATE OR BOTH HAD BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES OR CLAIM, MARKETING AFFILIATE AGREES TO DEFEND, INDEMNIFY AND HOLD HARMLESS EQUIDATA, AND EACH OF ITS EMPLOYEES, AGENTS, OFFICERS AND DIRECTORS, FROM AND AGAINST ANY CLAIM, SUIT, DEMAND, OR ACTION, INCLUDING WITHOUT LIMITATION ATTORNEY FEES, ARISING FROM (A) BREACH OF THIS AGREEMENT BY MARKETING AFFILIATE, (B) THE MARKETING AFFILIATE WEB SITE, OR (C) MARKETING AFFILIATE’S BUSINESS."
  },
  {
    "contract_id": "TheglobeComInc_19990503_S-1A_EX-10.20_5416126_EX-10.20_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding Agreement between theglobe.com, Inc. and The Boxlot Company:\n\n**Purpose:** The Co-Branding Agreement aims to establish a partnership between theglobe.com and The Boxlot Company to co-brand the Service, a web-based platform, and create a joint online presence.\n\n**Obligations:**\n\n* theglobe.com is responsible for delivering Page Templates and other materials to Boxlot by March 31, 1999.\n* Boxlot must develop the Co-Branded Pages using the Page Templates and take necessary steps to co-brand the Service.\n* Both parties are responsible for their respective development, hosting, and other costs associated with the pages living on their servers.\n\n**Risks:** Failure to comply with the agreement's terms may result in delays or disruptions to the co-branded Service, potentially affecting revenue and user experience. Additionally, Boxlot's unauthorized changes to the Service's look and feel or implementation of community features without theglobe's consent may lead to conflicts and reputational damage.",
    "termination": "8.2 Termination for Failure to Perform. By providing written notice, a\nparty may immediately terminate this Agreement: (a) if the other party\nmaterialally breaches this Agreement and fails to cure that breach within 15 days\nafter receiving written notice of the breach, or (b) as provided in Sections 2.6 [Boxlot Content]\nor 12.7 [Force Majeure] or Exhibit B. In addition, by providing written notice, theglobe may\nimmediately terminate this Agreement, or at its option immediately suspend its\npromotion and other efforts hereunder, in the case of Boxlot's breach of Section\n12.1 [Compliance with Laws].\n\n8.3 Termination for Change of Control. By providing written notice,\ntheglobe may terminate this Agreement in its sole discretion if one of the\nfollowing companies (or their subsidiaries) does an \"Ownership Change Event\":\nLycos, Yahoo (including GeoCities, which shall be included even if their\nproposed merger does not occur), Xoom, Fortune City, Excite, Go Network\n(including Disney and Infoseek), Snap! (including NBC) and AOL. An \"Ownership\nChange Event\" means: (x) the acquisition of 50% or more of Boxlot's equity or\nvoting interests; (y) a merger or consolidation of Boxlot; or (z) the sale,\nexchange or transfer of all or substantially all of Boxlot's assets related to\nthe Service.\n\n8.4 Termination for Changes. By providing written notice, theglobe may\nterminate this Agreement in its sole discretion if: (a) Boxlot's business model\nchanges such that the Service is no longer Boxlot's primary line of business, or\n(b) at the one year anniversary of the Launch Date, the Service is significantly\ninferior to the comparable services being offered by the",
    "confidentiality": "\"\"The parties agree to maintain the confidentiality of all information\nexchanged between them in connection with this Agreement, and not to\ndisclose such information to any third party, except as required by law or\nas permitted hereunder. This obligation of confidentiality shall survive the\nexpiration or termination of this Agreement for a period of two (2) years\nfrom the date of termination.\"\"",
    "liability": "NEITHER PARTY SHALL BE LIABLE FOR LOST PROFITS OR\nSPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES (HOWEVER ARISING, INCLUDING\nNEGIGENCE) ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, EVEN IF THE\nPARTIES ARE AWARE OF THE POSSIBILITY OF SUCH DAMAGES."
  },
  {
    "contract_id": "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement",
    "summary": "Here is a 100-150 word summary of the Co-Branding Agreement:\n\n**Purpose:** The Co-Branding Agreement, effective August 22, 2005, aims to establish a business relationship between Skype, Skype Holding, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited. The parties wish to terminate the Memorandum of Terms dated October 12, 2004, and enter into this agreement to grant the Company (or Online BVI) rights to provide co-marketing and co-branding activities.\n\n**Obligations:** The parties agree to:\n\n* Grant the Company (or Online BVI) rights to provide co-marketing and co-branding activities\n* Expand the business relationship among the parties as mutually agreed\n* Develop and host a co-branded web site or web site content featuring the Online Group's and Skype's brand features\n\n**Risks:** The agreement involves risks associated with co-branding and co-marketing activities, including potential conflicts of interest, intellectual property disputes, and reputational risks. The parties must carefully manage these risks to ensure the success of their business relationship.",
    "termination": "\"\"\"\"termination fees and collection charges\n• Alliance fees payable to handset manufacturers and/or mobile operators\n• Fees payable to payment agencies such as online-banking charges and charges of collection agents and banks for\npayment collection\n• Technology license fees approved by Skype and Online BVI in writing\n• Other costs approved by Skype and Online BVI in writing.\"\"\"",
    "confidentiality": "\"\"Confidential Information” shall have the meaning set forth in Section 11 herein.\"",
    "liability": "\"\"Each of Skype, Skype Holding, Online BVI, and Tom Holding are parties to that certain Memorandum of Terms dated October 12, 2004 (\"Memorandum\"), pursuant to which Skype and Online BVI have, among other things, agreed to (i) create, market and distribute a co-branded, customized version of the Skype Software (as defined below) to be distributed in the PRC (as defined below) by incorporating certain brand features of the Online Group (as defined below), and, (ii) develop and host a co-branded web site or web site content featuring the Online Group’s and Skype’s brand features as related to the customized version of the Skype Software to be distributed in the PRC;\"\""
  },
  {
    "contract_id": "TubeMediaCorp_20060310_8-K_EX-10.1_513921_EX-10.1_Affiliate Agreement",
    "summary": "Here is a 100-150 word summary of the Charter Affiliate Affiliation Agreement:\n\n**Purpose:** The agreement is between The TUBE Music Network, Inc. (the Network) and Tribune Broadcasting Company (the Affiliate) to establish a television programming service called \"The TUBE\" and outline the terms of their affiliation.\n\n**Obligations:** The Affiliate is obligated to provide the Service to its licensed communities, while the Network is responsible for providing the programming content. The Affiliate must also pay a share of the advertising revenue generated by the Service, as defined in Exhibit D.\n\n**Risks:** The agreement outlines various risks, including costs associated with losses, liabilities, claims, and damages. The Affiliate may also be subject to fines and forfeitures if it fails to comply with FCC regulations. The Network may also face risks related to the sale of products and services through direct response telephone orders and e-commerce sales.",
    "termination": "\"\"(i) During the Term and for one (1) year thereafter, Network shall maintain accurate and complete books and records in accordance with generally accepted accounting principles and practices that shall contain sufficient information to enable an auditor to verify, for the period under audit, Network’s Advertising Revenue, Network’s Transactional Revenue, the Affiliate Advertising Share, the Affiliate Transactional Share and the accuracy of the amounts paid by Network to Affiliate hereunder, including under Exhibit D (collectively, the “Revenue Share Records”). \"\"\"",
    "confidentiality": "\"Any officer, employee, consultant or agent of Affiliate that has access to an audit report (who shall be limited to those who are members of Affiliate’s corporate audit staff and have a specific need to know the contents thereof) shall also execute a confidentiality agreement consistent with the prior sentence.\"",
    "liability": "\"liabilities, claims, costs, damages and expenses, including fines, forfeitures, reasonable attorneys’ and expert witness fees, disbursements and court or administrative costs.\""
  },
  {
    "contract_id": "UnionDentalHoldingsInc_20050204_8-KA_EX-10_3345577_EX-10_Affiliate Agreement",
    "summary": "Here is a 100-150 word summary of the Business Affiliate Agreement:\n\n**Purpose:** The Business Affiliate Agreement is entered into between Dr. George D. Green (the Business Affiliate) and UNION DENTAL CORP. (UDC) to facilitate the exchange of confidential information and provide services that involve the use and disclosure of such information.\n\n**Obligations:** Both parties are obligated to use and disclose confidential information only as permitted or required by the agreement or as otherwise required by law. They must report any unauthorized use or disclosure, maintain the security of confidential information, and require employees and agents to adhere to the same restrictions. Parties must also provide access to records and information, return or destroy confidential information upon termination, and mitigate any harm caused by unauthorized use or disclosure.\n\n**Risks:** Failure to comply with the agreement's terms may result in unauthorized use or disclosure of confidential information, which could lead to reputational damage, financial losses, and potential legal consequences.",
    "termination": "5. Term and Termination.\na. Term. This Agreement shall become effective on the Effective Date\nand shall continue in effect until either Party informs the other Party\nwith thirty (30) day prior written notice of termination of this Agreement.\nb. Termination. UDC may immediately terminate this Agreement without\nnotice and any related agreement if it determines that the Business\nAffiliate has breached a material provision of this Agreement or if the\nactivities contemplated under this Agreement will result in a violation of\nany federal or state law or if such Services would, in the",
    "confidentiality": "\"Confidential Information@ shall mean any and all information that a Party may reasonably expect to remain confidential and not shared with the general public at any time or that information that is protected by law.\"",
    "liability": "The respective rights and obligations of Business Affiliate and UDC under the provisions of Sections 3(g) [Responsibilities of the Parties] and 3(h) [Responsibilities of the Parties] and 6 shall survive the termination of this Agreement indefinitely.\n\nc. No Third Party Beneficiaries. Nothing express or implied in this Agreement is intended to confer, nor anything herein shall confer, upon any person other than the Parties hereto any rights, remedies, obligations, or liabilities whatsoever."
  },
  {
    "contract_id": "UsioInc_20040428_SB-2_EX-10.11_1723988_EX-10.11_Affiliate Agreement 2",
    "summary": "Here is a 100-150 word summary of the Affiliate Office Agreement between Network 1 Financial Corporation and Payment Data Systems, Inc.:\n\n**Purpose:** The purpose of this agreement is to establish an Affiliate Office to market Network 1's payment processing services and locate contractors to sell these services to commercial businesses.\n\n**Obligations:**\n\n* Affiliate (Payment Data Systems, Inc.) must use its best efforts to market and sell Network 1's services, locate contractors, and disclose information about prospective contractors to Network 1.\n* Affiliate must establish and maintain local offices for contractors, which must meet Network 1's standards.\n* Affiliate is responsible for purchasing and leasing equipment and software from Network 1 at established prices.\n\n**Risks:** The agreement requires Affiliate to disclose information about prospective contractors, which may pose a risk to Network 1's reputation. Additionally, Affiliate is responsible for guaranteeing payments owed to Network 1, which may expose Affiliate to financial risk.",
    "termination": "\"\"\"\"termination whether to accept\nor not accept each prospective Contractor.\"\"\"",
    "confidentiality": "\"\"\"\"EXHIBIT 10.11\nNETWORK 1 FINANCIAL CORPORATION\nAFFILIATE OFFICE AGREEMENT\nTHIS AGREEMENT is entered into by and between NETWORK 1 FINANCIAL, INC.\n(\"NETWORK 1\"), a Virginia Corporation with its principal place of business at\n1501 Farm Credit Drive, Suite 1500, McLean, Virginia 22102-5004, and Payment\nData Systems, Inc., the Affiliate Office (\"AFFILIATE\"), a Nevada Corporation\nwith its principal place of business at 12500 San Pedro Suite 120 San Antonio,\nTX 78216. NETWORK 1 and Affiliate hereby agree as follows:\"\"\"",
    "liability": "3.03 LOSSES. All losses or charges arising from acts or omissions of the\nAffiliate, Contractors located by the Affiliate, or arising from transactions,\nchargebacks, lost revenues due to account cancellation or rejected fee\ncollections, acts or omissions of Merchants obtained by Contractors located by\nAffiliate shall be borne as set out in Exhibit C."
  },
  {
    "contract_id": "VgrabCommunicationsInc_20200129_10-K_EX-10.33_11958828_EX-10.33_Development Agreement",
    "summary": "Here is a 100-150 word summary of the Mobile Application Development Agreement:\n\n**Purpose:** The purpose of this agreement is to engage VGrab Asia Ltd. (VAL) with a group of private software developers (Developer) to design and develop the Duesey Coffee Chinese Mobile Apps and backend software for iPhone, iPad, and Android.\n\n**Obligations:** VAL is responsible for providing graphics, design, and artwork requirements for the project, while the Developer will design and develop the mobile app according to the requirements specifications. The Developer will also register a WeChat Official Account on behalf of VAL. The parties agree to collaborate and coordinate through regular status updates and weekly calls.\n\n**Risks:** The agreement outlines the risks associated with the project, including the possibility of delays or termination. The parties agree to perform their respective obligations and duties under the agreement, and any disputes will be resolved through negotiation or mediation. The agreement also specifies the payment terms, with payments to be made within 7 days upon completion of the project.",
    "termination": "VAL shall, in the event of Developer committing any breach of any of the terms and conditions of this\nagreement or for any other reason considered as sufficient, be entitled to terminate this agreement by\ngiving two (2) weeks’ notice in writing and it is applicable only when the project is not completed. If\nthe customer terminates the agreement, then VAL shall compensate the Developer up to the date of\ntermination with a fee calculated on Pro-rata basis. Developer may also terminate this Agreement by\ngiving two (2) weeks’ notice in writing to VAL. It is applicable only when the project is not completed.\nIn case Developer terminates the agreement, it shall handover the entire project related IPR, work\ndone till date to VAL.",
    "confidentiality": "\"\"\"\"CONFIDENTIAL\nSource: VGRAB COMMUNICATIONS INC., 10-K, 1/29/2020\"\"",
    "liability": "\"\"Either Party may request hard copy of any document that has been previously transmitted by electronic means provided however, that any such request shall in no manner delay the parties from performing their respective obligations and duties under EDT instruments.\"\""
  }
]